{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:28:15Z","timestamp":1788830895941,"version":"build-2803163510"},"reference-count":467,"publisher":"National Institute for Health and Care Research","issue":"44","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["NIHR129020"],"award-info":[{"award-number":["NIHR129020"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"Background<\/jats:title>Coeliac disease is an autoimmune disorder triggered by ingesting gluten. It affects approximately 1% of the UK population, but only one in three people is thought to have a diagnosis. Untreated coeliac disease may lead to malnutrition, anaemia, osteoporosis and lymphoma.<\/jats:p><\/jats:sec>Objectives<\/jats:title>The objectives were to define at-risk groups and determine the cost-effectiveness of active case-finding strategies in primary care.<\/jats:p><\/jats:sec>Design<\/jats:title>(1) Systematic review of the accuracy of potential diagnostic indicators for coeliac disease. (2) Routine data analysis to develop prediction models for identification of people who may benefit from testing for coeliac disease. (3) Systematic review of the accuracy of diagnostic tests for coeliac disease. (4) Systematic review of the accuracy of genetic tests for coeliac disease (literature search conducted in April 2021). (5) Online survey to identify diagnostic thresholds for testing, starting treatment and referral for biopsy. (6) Economic modelling to identify the cost-effectiveness of different active case-finding strategies, informed by the findings from previous objectives.<\/jats:p><\/jats:sec>Data sources<\/jats:title>For the first systematic review, the following databases were searched from 1997 to April 2021: MEDLINE\u00ae<\/jats:sup>(National Library of Medicine, Bethesda, MD, USA), Embase\u00ae<\/jats:sup>(Elsevier, Amsterdam, the Netherlands), Cochrane Library, Web of Science\u2122 (Clarivate\u2122, Philadelphia, PA, USA), the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) and the National Institutes of Health Clinical Trials database. For the second systematic review, the following databases were searched from January 1990 to August 2020: MEDLINE, Embase, Cochrane Library, Web of Science, Kleijnen Systematic Reviews (KSR) Evidence, WHO ICTRP and the National Institutes of Health Clinical Trials database. For prediction model development, Clinical Practice Research Datalink GOLD, Clinical Practice Research Datalink Aurum and a subcohort of the Avon Longitudinal Study of Parents and Children were used; for estimates for the economic models, Clinical Practice Research Datalink Aurum was used.<\/jats:p><\/jats:sec>Review methods<\/jats:title>For review 1, cohort and case\u2013control studies reporting on a diagnostic indicator in a population with and a population without coeliac disease were eligible. For review 2, diagnostic cohort studies including patients presenting with coeliac disease symptoms who were tested with serological tests for coeliac disease and underwent a duodenal biopsy as reference standard were eligible. In both reviews, risk of bias was assessed using the quality assessment of diagnostic accuracy studies 2 tool. Bivariate random-effects meta-analyses were fitted, in which binomial likelihoods for the numbers of true positives and true negatives were assumed.<\/jats:p><\/jats:sec>Results<\/jats:title>People with dermatitis herpetiformis, a family history of coeliac disease, migraine, anaemia, type 1 diabetes, osteoporosis or chronic liver disease are 1.5\u20132 times more likely than the general population to have coeliac disease; individual gastrointestinal symptoms were not useful for identifying coeliac disease. For children, women and men, prediction models included 24, 24 and 21 indicators of coeliac disease, respectively. The models showed good discrimination between patients with and patients without coeliac disease, but performed less well when externally validated. Serological tests were found to have good diagnostic accuracy for coeliac disease. Immunoglobulin A tissue transglutaminase had the highest sensitivity and endomysial antibody the highest specificity. There was little improvement when tests were used in combination. Survey respondents (n<\/jats:italic>\u2009=\u2009472) wanted to be 66% certain of the diagnosis from a blood test before starting a gluten-free diet if symptomatic, and 90% certain if asymptomatic. Cost-effectiveness analyses found that, among adults, and using serological testing alone, immunoglobulin A tissue transglutaminase was most cost-effective at a 1% pre-test probability (equivalent to population screening). Strategies using immunoglobulin A endomysial antibody plus human leucocyte antigen or human leucocyte antigen plus immunoglobulin A tissue transglutaminase with any pre-test probability had similar cost-effectiveness results, which were also similar to the cost-effectiveness results of immunoglobulin A tissue transglutaminase at a 1% pre-test probability. The most practical alternative for implementation within the NHS is likely to be a combination of human leucocyte antigen and immunoglobulin A tissue transglutaminase testing among those with a pre-test probability above 1.5%. Among children, the most cost-effective strategy was a 10% pre-test probability with human leucocyte antigen plus immunoglobulin A tissue transglutaminase, but there was uncertainty around the most cost-effective pre-test probability. There was substantial uncertainty in economic model results, which means that there would be great value in conducting further research.<\/jats:p><\/jats:sec>Limitations<\/jats:title>The interpretation of meta-analyses was limited by the substantial heterogeneity between the included studies, and most included studies were judged to be at high risk of bias. The main limitations of the prediction models were that we were restricted to diagnostic indicators that were recorded by general practitioners and that, because coeliac disease is underdiagnosed, it is also under-reported in health-care data. The cost-effectiveness model is a simplification of coeliac disease and modelled an average cohort rather than individuals. Evidence was weak on the probability of routine coeliac disease diagnosis, the accuracy of serological and genetic tests and the utility of a gluten-free diet.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>Population screening with immunoglobulin A tissue transglutaminase (1% pre-test probability) and of immunoglobulin A endomysial antibody followed by human leucocyte antigen testing or human leucocyte antigen testing followed by immunoglobulin A tissue transglutaminase with any pre-test probability appear to have similar cost-effectiveness results. As decisions to implement population screening cannot be made based on our economic analysis alone, and given the practical challenges of identifying patients with higher pre-test probabilities, we recommend that human leucocyte antigen combined with immunoglobulin A tissue transglutaminase testing should be considered for adults with at least a 1.5% pre-test probability of coeliac disease, equivalent to having at least one predictor. A more targeted strategy of 10% pre-test probability is recommended for children (e.g. children with anaemia).<\/jats:p><\/jats:sec>Future work<\/jats:title>Future work should consider whether or not population-based screening for coeliac disease could meet the UK National Screening Committee criteria and whether or not it necessitates a long-term randomised controlled trial of screening strategies. Large prospective cohort studies in which all participants receive accurate tests for coeliac disease are needed.<\/jats:p><\/jats:sec>Study registration<\/jats:title>This study is registered as PROSPERO CRD42019115506 and CRD42020170766.<\/jats:p><\/jats:sec>Funding<\/jats:title>This project was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme and will be published in full inHealth Technology Assessment<\/jats:italic>; Vol. 26, No. 44. See the NIHR Journals Library website for further project information.<\/jats:p><\/jats:sec>","DOI":"10.3310\/zuce8371","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T11:33:25Z","timestamp":1667388805000},"page":"1-310","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling"],"prefix":"10.3310","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9824-9335","authenticated-orcid":true,"given":"Martha MC","family":"Elwenspoek","sequence":"first","affiliation":[{"name":"National Institute for Health and Care Research Applied Research Collaboration West, University Hospitals Bristol NHS Foundation Trust, Bristol, UK"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8576-5552","authenticated-orcid":true,"given":"Howard","family":"Thom","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1564-0740","authenticated-orcid":true,"given":"Athena L","family":"Sheppard","sequence":"additional","affiliation":[{"name":"National Institute for Health and Care Research Applied Research Collaboration West, University Hospitals Bristol NHS Foundation Trust, Bristol, UK"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"},{"name":"Department of Health Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4763-8891","authenticated-orcid":true,"given":"Edna","family":"Keeney","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4354-8135","authenticated-orcid":true,"given":"Rachel","family":"O\u2019Donnell","sequence":"additional","affiliation":[{"name":"National Institute for Health and Care Research Applied Research Collaboration West, University Hospitals Bristol NHS Foundation Trust, Bristol, UK"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2591-7395","authenticated-orcid":true,"given":"Joni","family":"Jackson","sequence":"additional","affiliation":[{"name":"National Institute for Health and Care Research Applied Research Collaboration West, University Hospitals Bristol NHS Foundation Trust, Bristol, UK"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6279-6823","authenticated-orcid":true,"given":"Cristina","family":"Roadevin","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-063X","authenticated-orcid":true,"given":"Sarah","family":"Dawson","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Lane","sequence":"additional","affiliation":[{"name":"Patient representative, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Stubbs","sequence":"additional","affiliation":[{"name":"Patient representative, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7362-8403","authenticated-orcid":true,"given":"Hazel","family":"Everitt","sequence":"additional","affiliation":[{"name":"Primary Care Research Centre, Population Sciences and Medical Education, University of Southampton, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8177-6438","authenticated-orcid":true,"given":"Jessica C","family":"Watson","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3012-375X","authenticated-orcid":true,"given":"Alastair D","family":"Hay","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2294-4478","authenticated-orcid":true,"given":"Peter","family":"Gillett","sequence":"additional","affiliation":[{"name":"Paediatric Gastroenterology, Hepatology and Nutrition Department, Royal Hospital for Sick Children, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7249-4412","authenticated-orcid":true,"given":"Gerry","family":"Robins","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, York Teaching Hospital NHS Foundation Trust, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4265-2854","authenticated-orcid":true,"given":"Hayley E","family":"Jones","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0596-8200","authenticated-orcid":true,"given":"Sue","family":"Mallett","sequence":"additional","affiliation":[{"name":"Centre for Medical Imaging, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1138-5682","authenticated-orcid":true,"given":"Penny F","family":"Whiting","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2022,10]]},"reference":[{"key":"key2022103115415165_ref1-bib1","volume-title":"Coeliac Disease","author":"BMJ Best Practice"},{"key":"key2022103115415165_ref1-bib2","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/bmj.328.7435.322","article-title":"Avon Longitudinal Study of Parents and Children Study Team. Undiagnosed coeliac disease at age seven: population based prospective birth cohort study","volume":"328","author":"Bingley","year":"2004","journal-title":"BMJ"},{"key":"key2022103115415165_ref1-bib3","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1097\/EDE.0000000000001006","article-title":"Changes in testing for and incidence of celiac disease in the United Kingdom: a population-based cohort study","volume":"30","author":"West","year":"2019","journal-title":"Epidemiology"},{"key":"key2022103115415165_ref1-bib4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/ajg.2014.55","article-title":"Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study","volume":"109","author":"West","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"key2022103115415165_ref1-bib5","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1001\/jama.281.24.2344","article-title":"Mortality in celiac disease, intestinal inflammation, and gluten sensitivity","volume":"302","author":"Green","year":"2009","journal-title":"JAMA"},{"key":"key2022103115415165_ref1-bib6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0140-6736(03)14027-5","article-title":"Coeliac disease","volume":"362","author":"Green","year":"2003","journal-title":"Lancet"},{"key":"key2022103115415165_ref1-bib7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.dld.2019.11.010","article-title":"Therapeutic options for coeliac disease: what else beyond gluten-free diet?","volume":"52","author":"Caio","year":"2020","journal-title":"Dig Liver Dis"},{"key":"key2022103115415165_ref1-bib8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12876-021-01737-1","article-title":"Is mass screening for coeliac disease a wise use of resources? A health economic evaluation","volume":"21","author":"Norstr\u00f6m","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"key2022103115415165_ref1-bib9","unstructured":"National Institute for Health and Care Excellence (NICE). Coeliac Disease: Recognition, Assessment and Management. NICE Guideline [NG20]. London: NICE; 2015."},{"key":"key2022103115415165_ref1-bib10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/MPG.0000000000002497","article-title":"European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020","volume":"70","author":"Husby","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/2050640619844125","article-title":"European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders","volume":"7","author":"Al-Toma","year":"2019","journal-title":"United European Gastroenterol J"},{"key":"key2022103115415165_ref1-bib12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/MPG.0b013e318216f2e5","article-title":"ESPGHAN Working Group on Coeliac Disease Diagnosis. Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report","volume":"54","author":"Giersiepen","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1053\/j.gastro.2005.02.028","article-title":"The diagnostic accuracy of serologic tests for celiac disease: a systematic review","volume":"128","author":"Rostom","year":"2005","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1177\/2050640613502788","article-title":"Serological testing for celiac disease in adults","volume":"1","author":"Schyum","year":"2013","journal-title":"United European Gastroenterol J"},{"key":"key2022103115415165_ref1-bib15","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1001\/jama.2010.549","article-title":"Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review","volume":"303","author":"van der Windt","year":"2010","journal-title":"JAMA"},{"key":"key2022103115415165_ref1-bib16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","article-title":"Coeliac disease","volume":"391","author":"Lebwohl","year":"2018","journal-title":"Lancet"},{"key":"key2022103115415165_ref1-bib17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1590\/S0102-67202015000300009","article-title":"The prevalence of HLA DQ2 and DQ8 in patients with celiac disease, in family and in general population","volume":"28","author":"Cecilio","year":"2015","journal-title":"Arq Bras Cir Dig"},{"key":"key2022103115415165_ref1-bib18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","article-title":"European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease","volume":"54","author":"Husby","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib19","unstructured":"British Society of Gastroenterology. BSG Interim Guidance: COVID-19 Specific Non-biopsy Protocol for Those with Suspected Coeliac Disease. London: British Society of Gastroenterology; 2020."},{"key":"key2022103115415165_ref1-bib20","doi-asserted-by":"publisher","first-page":"e0258501","DOI":"10.1371\/journal.pone.0258501","article-title":"The accuracy of diagnostic indicators for coeliac disease: a systematic review and meta-analysis","volume":"16","author":"Elwenspoek","year":"2021","journal-title":"PLOS ONE"},{"key":"key2022103115415165_ref1-bib21","doi-asserted-by":"publisher","first-page":"e038994","DOI":"10.1136\/bmjopen-2020-038994","article-title":"Accuracy of potential diagnostic indicators for coeliac disease: a systematic review protocol","volume":"10","author":"Elwenspoek","year":"2020","journal-title":"BMJ Open"},{"key":"key2022103115415165_ref1-bib22","unstructured":"Centre for Reviews and Dissemination. Systematic Reviews \u2013 CRD\u2019s Guidance for Undertaking Reviews in Healthcare. York: Centre for Reviews and Dissemination, University of York; 2009."},{"key":"key2022103115415165_ref1-bib23","volume-title":"Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0","author":"Deeks","year":"2013"},{"key":"key2022103115415165_ref1-bib24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","article-title":"Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: the PRISMA-DTA statement","volume":"319","author":"McInnes","year":"2018","journal-title":"JAMA"},{"key":"key2022103115415165_ref1-bib25","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1373\/clinchem.2005.048595","article-title":"Case\u2013control and two-gate designs in diagnostic accuracy studies","volume":"51","author":"Rutjes","year":"2005","journal-title":"Clin Chem"},{"key":"key2022103115415165_ref1-bib26","doi-asserted-by":"publisher","first-page":"e32844","DOI":"10.1371\/journal.pone.0032844","article-title":"Search filters for finding prognostic and diagnostic prediction studies in MEDLINE to enhance systematic reviews","volume":"7","author":"Geersing","year":"2012","journal-title":"PLOS ONE"},{"key":"key2022103115415165_ref1-bib27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1136\/jamia.2001.0080391","article-title":"Searching for clinical prediction rules in MEDLINE","volume":"8","author":"Ingui","year":"2001","journal-title":"J Am Med Inform Assoc"},{"key":"key2022103115415165_ref1-bib28","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"key2022103115415165_ref1-bib29","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"key2022103115415165_ref1-bib30","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.jclinepi.2006.06.011","article-title":"Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach","volume":"59","author":"Chu","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"key2022103115415165_ref1-bib31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/gutjnl-2011-301346","article-title":"The Oslo definitions for coeliac disease and related terms","volume":"62","author":"Ludvigsson","year":"2013","journal-title":"Gut"},{"key":"key2022103115415165_ref1-bib32","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","article-title":"Global prevalence of celiac disease: systematic review and meta-analysis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib33","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2020."},{"key":"key2022103115415165_ref1-bib34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"key":"key2022103115415165_ref1-bib35","volume-title":"PropCIs: Various Confidence Interval Methods for Proportions. R Package Version 0.3-0","author":"Scherer","year":"2018"},{"key":"key2022103115415165_ref1-bib36","volume-title":"Advanced Forest Plot Using \u2018grid\u2019 Graphics [R Package Version 1.10.1]","author":"Gordon","year":"2020"},{"key":"key2022103115415165_ref1-bib37","volume-title":"flextable: Functions for Tabular Reporting. R Package Version 0.5.11","author":"Gohel","year":"2020"},{"key":"key2022103115415165_ref1-bib38","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"key2022103115415165_ref1-bib39","volume-title":"mada: Meta-analysis of Diagnostic Accuracy. R Package Version 0.5.10","author":"Doebler","year":"2020"},{"key":"key2022103115415165_ref1-bib40","volume-title":"ellipse: Functions for Drawing Ellipses and Ellipse-like Confidence Regions. R Package Version 0.4.2","author":"Murdoch","year":"2020"},{"key":"key2022103115415165_ref1-bib41","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1136\/gutjnl-2013-306578","article-title":"Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology","volume":"63","author":"Ludvigsson","year":"2014","journal-title":"Gut"},{"key":"key2022103115415165_ref1-bib42","volume-title":"2019 Surveillance of Coeliac Disease: Recognition, Assessment and Management (NICE Guideline NG20)","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"key2022103115415165_ref1-bib43","volume-title":"Prediction Model for Coeliac Disease Diagnosis: Statistical Analysis Plan (SAP)","author":"Elwenspoek"},{"key":"key2022103115415165_ref1-bib44","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-16399-0","volume-title":"Clinical Prediction Models. A Practical Approach to Development, Validation, and Updating","author":"Steyerberg","year":"2019","edition":"2"},{"key":"key2022103115415165_ref1-bib45","doi-asserted-by":"publisher","first-page":"735","DOI":"10.7326\/L15-5093-2","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD)","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"key2022103115415165_ref1-bib46","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data Resource Profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"key2022103115415165_ref1-bib47","unstructured":"Clinical Practice Research Datalink. CPRD GOLD June 2021 (Version 2021.06.001). Clinical Practice Research Datalink; 2021. https:\/\/doi.org\/10.48329\/7308-xf35"},{"key":"key2022103115415165_ref1-bib48","volume-title":"National Statistics: English Indices of Deprivation 2019","author":"Ministry of Housing, Communities and Local Government"},{"key":"key2022103115415165_ref1-bib49","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1136\/gutjnl-2014-308285","article-title":"Causes of death in people with coeliac disease in England compared with the general population: a competing risk analysis","volume":"64","author":"Abdul Sultan","year":"2015","journal-title":"Gut"},{"key":"key2022103115415165_ref1-bib50","doi-asserted-by":"publisher","first-page":"e41308","DOI":"10.1371\/journal.pone.0041308","article-title":"Resource use and costs associated with coeliac disease before and after diagnosis in 3,646 cases: results of a UK primary care database analysis","volume":"7","author":"Violato","year":"2012","journal-title":"PLOS ONE"},{"key":"key2022103115415165_ref1-bib51","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/sim.7992","article-title":"Minimum sample size for developing a multivariable prediction model: PART II \u2013 binary and time-to-event outcomes","volume":"38","author":"Riley","year":"2019","journal-title":"Stat Med"},{"key":"key2022103115415165_ref1-bib52","unstructured":"World Organization of Family Doctors\u2019 International Classification Committee. International Classification of Primary Care (ICPC-2). 2nd edn. Oxford: Oxford University Press; 2015."},{"key":"key2022103115415165_ref1-bib53","doi-asserted-by":"publisher","first-page":"e000137","DOI":"10.1136\/bmjgast-2017-000137","article-title":"Epidemiology of coeliac disease in a single centre in Southern Derbyshire 1958\u20132014","volume":"4","author":"Holmes","year":"2017","journal-title":"BMJ Open Gastroenterol"},{"key":"key2022103115415165_ref1-bib54","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2288-8-48","article-title":"Advantages of the nested case\u2013control design in diagnostic research","volume":"8","author":"Biesheuvel","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"key2022103115415165_ref1-bib55","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1373\/clinchem.2009.134155","article-title":"Criteria for scientific evaluation of novel markers: a perspective","volume":"56","author":"Moons","year":"2010","journal-title":"Clin Chem"},{"key":"key2022103115415165_ref1-bib56","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M18-1377","article-title":"PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration","volume":"170","author":"Moons","year":"2019","journal-title":"Ann Intern Med"},{"key":"key2022103115415165_ref1-bib57","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/ije\/dyz034","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum","volume":"48","author":"Wolf","year":"2019","journal-title":"Int J Epidemiol"},{"key":"key2022103115415165_ref1-bib58","unstructured":"Clinical Practice Research Datalink. CPRD Aurum June 2021 (Version 2021.06.001). Clinical Practice Research Datalink; 2021. https:\/\/doi.org\/10.48329\/pyc2-we97"},{"key":"key2022103115415165_ref1-bib59","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1046\/j.1365-3016.2001.00325.x","article-title":"ALSPAC \u2013 the Avon Longitudinal Study of Parents and Children. I. Study methodology","volume":"15","author":"Golding","year":"2001","journal-title":"Paediatr Perinat Epidemiol"},{"key":"key2022103115415165_ref1-bib60","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/ije\/dys064","article-title":"Cohort profile: the \u2018Children of the 90s\u2018 \u2013 the index offspring of the Avon Longitudinal Study of Parents and Children","volume":"42","author":"Boyd","year":"2013","journal-title":"Int J Epidemiol"},{"key":"key2022103115415165_ref1-bib61","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/ije\/dys066","article-title":"Cohort profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort","volume":"42","author":"Fraser","year":"2013","journal-title":"Int J Epidemiol"},{"key":"key2022103115415165_ref1-bib62","unstructured":"Great Britain. Human Tissue Act 2004. London: The Stationery Office; 2004."},{"key":"key2022103115415165_ref1-bib63","volume-title":"Explore Data and Samples","author":"University of Bristol"},{"key":"key2022103115415165_ref1-bib64","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/sim.1047","article-title":"A solution to the problem of separation in logistic regression","volume":"21","author":"Heinze","year":"2002","journal-title":"Stat Med"},{"key":"key2022103115415165_ref1-bib65","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"key":"key2022103115415165_ref1-bib66","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-19425-7","volume-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis","author":"Harrell","year":"2015","edition":"2"},{"key":"key2022103115415165_ref1-bib67","volume-title":"National Statistics: English Indices of Deprivation 2015","author":"Ministry of Housing, Communities and Local Government"},{"key":"key2022103115415165_ref1-bib68","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jclinepi.2013.05.014","article-title":"A systematic review classifies sources of bias and variation in diagnostic test accuracy studies","volume":"66","author":"Whiting","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"key2022103115415165_ref1-bib69","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/MCG.0000000000001081","article-title":"Diagnostic accuracy of point of care tests for diagnosing celiac disease: a systematic review and meta-analysis","volume":"53","author":"Singh","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"key2022103115415165_ref1-bib70","first-page":"209","article-title":"The serological diagnosis of coeliac disease \u2013 a step forward","volume":"11","author":"Holmes","year":"2018","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"key2022103115415165_ref1-bib71","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan \u2013 a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"key2022103115415165_ref1-bib72","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.7326\/M21-2234","article-title":"QUADAS-C: a tool for assessing risk of bias in comparative diagnostic accuracy studies","volume":"174","author":"Yang","year":"2021","journal-title":"Ann Intern Med"},{"key":"key2022103115415165_ref1-bib73","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41512-017-0023-0","article-title":"Understanding test accuracy research: a test consequence graphic","volume":"2","author":"Whiting","year":"2018","journal-title":"Diagn Progn Res"},{"key":"key2022103115415165_ref1-bib74","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.cgh.2017.04.025","article-title":"Prevalence of celiac disease autoimmunity among adolescents and young adults in China","volume":"15","author":"Yuan","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib75","volume-title":"What is the Accuracy of Serological Testing for Diagnosing Coeliac Disease in Adults and Children? A Systematic Review","author":"Sheppard"},{"key":"key2022103115415165_ref1-bib76","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.cgh.2006.02.010","article-title":"Utility in clinical practice of immunoglobulin A anti-tissue transglutaminase antibody for the diagnosis of celiac disease","volume":"4","author":"Abrams","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib77","doi-asserted-by":"publisher","first-page":"232","DOI":"10.5001\/omj.2013.68","article-title":"Diagnostic utility of coeliac disease: a descriptive study in a tertiary care hospital, Oman","volume":"28","author":"Al Saidi","year":"2013","journal-title":"Oman Med J"},{"key":"key2022103115415165_ref1-bib78","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s10875-008-9200-9","article-title":"Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease","volume":"28","author":"Ashorn","year":"2008","journal-title":"J Clin Immunol"},{"key":"key2022103115415165_ref1-bib79","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1055\/s-0033-1359200","article-title":"Prediction of celiac disease at endoscopy","volume":"46","author":"Barada","year":"2014","journal-title":"Endoscopy"},{"key":"key2022103115415165_ref1-bib80","first-page":"20","article-title":"Diagnostic accuracy of IgA anti-tissue transglutaminase in celiac disease in Van \u2013 Turkey","volume":"20","author":"Bayram","year":"2015","journal-title":"East J Med"},{"key":"key2022103115415165_ref1-bib81","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1093\/clinchem\/48.9.1546","article-title":"Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study","volume":"48","author":"Carroccio","year":"2002","journal-title":"Clin Chem"},{"key":"key2022103115415165_ref1-bib82","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1373\/clinchem.2005.061366","article-title":"Anti-transglutaminase antibody assay of the culture medium of intestinal biopsy specimens can improve the accuracy of celiac disease diagnosis","volume":"52","author":"Carroccio","year":"2006","journal-title":"Clin Chem"},{"key":"key2022103115415165_ref1-bib83","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1365-2036.2010.04337.x","article-title":"Antibodies against deamidated gliadin peptides identify adult coeliac disease patients negative for antibodies against endomysium and tissue transglutaminase","volume":"32","author":"Dahle","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"key2022103115415165_ref1-bib84","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s10620-009-0789-1","article-title":"Suboptimal performance of IgG anti-tissue transglutaminase in the diagnosis of celiac disease in a tropical country","volume":"55","author":"Dutta","year":"2010","journal-title":"Dig Dis Sci"},{"key":"key2022103115415165_ref1-bib85","first-page":"141","article-title":"Diagnostic accuracy of IgA anti-tissue transglutaminase in patients suspected of having coeliac disease in Iran","volume":"17","author":"Emami","year":"2008","journal-title":"J Gastrointestin Liver Dis"},{"key":"key2022103115415165_ref1-bib86","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2478\/v10011-011-0047-x","article-title":"Diagnostic accuracy of IGA anti-tissue transglutaminase antibody testing in celiac disease","volume":"31","author":"Eremic","year":"2012","journal-title":"J Med Biochem"},{"key":"key2022103115415165_ref1-bib87","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1157\/13078992","article-title":"Usefulness of anti-transglutaminase antibodies in the diagnosis of celiac disease","volume":"28","author":"Fern\u00e1ndez","year":"2005","journal-title":"Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib88","doi-asserted-by":"publisher","first-page":"294","DOI":"10.7326\/0003-4819-147-5-200709040-00003","article-title":"Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease","volume":"147","author":"Hadithi","year":"2007","journal-title":"Ann Intern Med"},{"key":"key2022103115415165_ref1-bib89","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/MEG.0000000000000841","article-title":"Coeliac disease: further evidence that biopsy is not always necessary for diagnosis","volume":"29","author":"Holmes","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib90","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cgh.2007.12.008","article-title":"What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis","volume":"6","author":"Hopper","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib91","first-page":"47","article-title":"Diagnostic accuracy of antibodies to deamidated gliadin peptides","volume":"44","author":"Jarmi","year":"2010","journal-title":"Acta Bioquim Clin Latinoam"},{"key":"key2022103115415165_ref1-bib92","first-page":"15","article-title":"Diagnostic accuracy of IgA anti-tissue transglutaminase antibodies in comparison with histopathological findings in celiac disease in Pakistan","volume":"25","author":"Javaeed","year":"2014","journal-title":"Medical Forum Mon"},{"key":"key2022103115415165_ref1-bib93","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/00042737-200309000-00010","article-title":"A comparison of antibodies to tissue transglutaminase with conventional serological tests in the diagnosis of coeliac disease","volume":"15","author":"Johnston","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib94","first-page":"475","article-title":"Prevalence of celiac disease and role of anti-tissue transglutaminase antibodies in different types of intestinal damage in celiac disease according to Marsh classification","volume":"11","author":"Kashif","year":"2017","journal-title":"Pakistan J Medical Health Sci"},{"key":"key2022103115415165_ref1-bib95","first-page":"A22","article-title":"Does IgA tissue transglutaminase antibody levels correlate with histological findings of coeliac disease (CD)?","volume":"1","author":"Kurien","year":"2013","journal-title":"United European Gastroenterol J"},{"key":"key2022103115415165_ref1-bib96","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/s41395-018-0143-3","article-title":"Office-based point of care testing (IgA\/IgG-deamidated gliadin peptide) for celiac disease","volume":"113","author":"Lau","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"key2022103115415165_ref1-bib97","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1373\/clinchem.2003.024976","article-title":"IgA antibodies against tissue transglutaminase in the diagnosis of celiac disease: concordance with intestinal biopsy in children and adults","volume":"50","author":"Llorente","year":"2004","journal-title":"Clin Chem"},{"key":"key2022103115415165_ref1-bib98","first-page":"A278","article-title":"How does specific serology match with esphgan serologic guidelines for diagnosis of celiac disease in a prospective cohort of adults with high pretest probability?","volume":"2","author":"Longarini","year":"2014","journal-title":"United European Gastroenterol J"},{"key":"key2022103115415165_ref1-bib99","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085%2814%2961693-0","article-title":"Point of care testing for adult celiac disease: a novel role in endoscopy","volume":"146","author":"Mooney","year":"2014","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib100","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.cgh.2015.01.010","article-title":"Increased detection of celiac disease with measurement of deamidated gliadin peptide antibody before endoscopy","volume":"13","author":"Mooney","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib101","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1373\/clinchem.2006.081364","article-title":"Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease","volume":"53","author":"Niveloni","year":"2007","journal-title":"Clin Chem"},{"key":"key2022103115415165_ref1-bib102","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s10620-014-3143-1","article-title":"Clinical utility of celiac disease-associated HLA testing","volume":"59","author":"Pallav","year":"2014","journal-title":"Dig Dis Sci"},{"key":"key2022103115415165_ref1-bib103","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/MPG.0000000000001773","article-title":"Celiac disease diagnosis without biopsy: is a 10\u00d7 ULN anti-transglutaminase result suitable for a chemiluminescence method?","volume":"66","author":"Previtali","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib104","first-page":"131","article-title":"Correlation of tissue transglutaminase antibody with duodenal histologic marsh grading","volume":"6","author":"Rahmati","year":"2014","journal-title":"Middle East J Dig Dis"},{"key":"key2022103115415165_ref1-bib105","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/00042737-200605000-00006","article-title":"Diagnostic accuracy of coeliac serological tests: a prospective study","volume":"18","author":"Reeves","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib106","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/j.1365-2036.2008.03652.x","article-title":"Diagnostic value of duodenal antitissue transglutaminase antibodies in gluten-sensitive enteropathy","volume":"27","author":"Santaolalla","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"key2022103115415165_ref1-bib107","first-page":"41","article-title":"Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies","volume":"19","author":"Sayed","year":"2012","journal-title":"Egypt J Immunol"},{"key":"key2022103115415165_ref1-bib108","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/j.1572-0241.2003.07455.x","article-title":"Is intestinal biopsy always needed for diagnosis of celiac disease?","volume":"98","author":"Scoglio","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"key2022103115415165_ref1-bib109","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.3748\/wjg.v16.i25.3144","article-title":"Celiac disease serology in patients with different pretest probabilities: is biopsy avoidable?","volume":"16","author":"Sugai","year":"2010","journal-title":"World J Gastroenterol"},{"key":"key2022103115415165_ref1-bib110","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/cei.12000","article-title":"Quality not quantity for transglutaminase antibody 2: the performance of an endomysial and tissue transglutaminase test in screening coeliac disease remains stable over time","volume":"171","author":"Swallow","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"key2022103115415165_ref1-bib111","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1046\/j.1365-2036.2003.01595.x","article-title":"Antibodies to human recombinant tissue transglutaminase may detect coeliac disease patients undiagnosed by endomysial antibodies","volume":"17","author":"Tesei","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"key2022103115415165_ref1-bib112","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/MCG.0b013e3181c378f6","article-title":"Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis","volume":"44","author":"Volta","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"key2022103115415165_ref1-bib113","first-page":"A77","article-title":"IgA antibody to tissue transglutaminase is a highly sensitive predictor of adult onset coeliac disease in clinical practice","volume":"48","author":"Whyte","year":"2001","journal-title":"Gut"},{"key":"key2022103115415165_ref1-bib114","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.dld.2011.10.013","article-title":"High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease","volume":"44","author":"Zanini","year":"2012","journal-title":"Dig Liver Dis"},{"key":"key2022103115415165_ref1-bib115","first-page":"60","volume-title":"Utility of Anti Deamidated Gliadin Peptides Antibodies in the Screening of Celiac Disease in Children","author":"Pretto"},{"key":"key2022103115415165_ref1-bib116","first-page":"203","article-title":"Diagnostic accuracy of serum anti-tissue transglutaminase IgA, in the diagnosis of celiac disease, taking small bowel biopsy as a gold standard","volume":"39","author":"Rabbani","year":"2015","journal-title":"Pak Paediatr J"},{"key":"key2022103115415165_ref1-bib117","doi-asserted-by":"publisher","first-page":"E2179","DOI":"10.3390\/jcm8122179","article-title":"Efficacy study of anti-endomysium antibodies for celiac disease diagnosis: a retrospective study in a Spanish pediatric population","volume":"8","author":"Roca","year":"2019","journal-title":"J Clin Med"},{"key":"key2022103115415165_ref1-bib118","first-page":"S58","article-title":"Diagnostic value of serologic tests in celiac screening","volume":"3","author":"Saneian","year":"2012","journal-title":"Int J Prev Med"},{"key":"key2022103115415165_ref1-bib119","doi-asserted-by":"publisher","first-page":"S350","DOI":"10.1016\/S1590-8658(10)60615-9","article-title":"Antibodies against synthetic deamidated gliadin peptides for the diagnosis of childhood celiac disease: do they play a role?","volume":"42","author":"Tronconi","year":"2010","journal-title":"Dig Liver Dis"},{"key":"key2022103115415165_ref1-bib120","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/00042737-200201000-00012","article-title":"Tissue transglutaminase and endomysial autoantibodies measured in an historical cohort of children and young adults in whom coeliac disease was suspected","volume":"14","author":"Weile","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib121","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1053\/j.gastro.2017.04.023","article-title":"Validation of antibody-based strategies for diagnosis of pediatric celiac disease without biopsy","volume":"153","author":"Wolf","year":"2017","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib122","doi-asserted-by":"publisher","first-page":"S277","DOI":"10.1016\/S0016-5085(12)61048-8","article-title":"Tissue transglutaminase antibody levels \u2265\u2009100 U\/mL and celiac disease: the first prospective study","volume":"142","author":"Mubarak","year":"2012","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib123","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/j.1651-2227.2010.02124.x","article-title":"Clinical accuracy of anti-tissue transglutaminase as screening test for celiac disease under 2 years","volume":"100","author":"Panetta","year":"2011","journal-title":"Acta Paediatr"},{"key":"key2022103115415165_ref1-bib124","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1128\/CVI.00205-09","article-title":"Performance of serology assays for diagnosing celiac disease in a clinical setting","volume":"16","author":"Parizade","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"key2022103115415165_ref1-bib125","first-page":"E16","article-title":"The use of tissue transglutaminase IGG antibody (TTG-G) in the diagnosis of celiac disease","volume":"49","author":"Pettie","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib126","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/MCG.0b013e31802fc1e3","article-title":"Is tissue transglutaminase autoantibody the best for diagnosing celiac disease in children of developing countries?","volume":"42","author":"Poddar","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"key2022103115415165_ref1-bib127","first-page":"9","article-title":"Relation of anti-tissue transglutaminase IgA antibodies with the morphology of the intestinal mucosa in children with celiac disease","volume":"21","author":"Polanco","year":"2001","journal-title":"Pediatrika"},{"key":"key2022103115415165_ref1-bib128","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/MPG.0b013e3182645c54","article-title":"Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease","volume":"55","author":"Olen","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib129","first-page":"167","article-title":"Validation of the ESPGHAN guidelines for the diagnosis of coeliac disease in a Canadian population","volume":"130","author":"Nguyen","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib130","doi-asserted-by":"publisher","first-page":"A3","DOI":"10.1136\/archdischild-2014-306237.7","article-title":"Coeliac serology testing in Irish children \u2013 a substitute for biopsy?","volume":"99","author":"Kutty","year":"2014","journal-title":"Arch Dis Child"},{"key":"key2022103115415165_ref1-bib131","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/j.1600-0463.2011.02817.x","article-title":"Immunoglobulin G antibodies against deamidated-gliadin-peptides outperform anti-endomysium and tissue transglutaminase antibodies in children <\u20092 years age","volume":"119","author":"Mubarak","year":"2011","journal-title":"APMIS"},{"key":"key2022103115415165_ref1-bib132","doi-asserted-by":"publisher","first-page":"469","DOI":"10.14735\/amgh2017csgh.info07","article-title":"Evaluation and applicability of nonbiopsy criteria in children and adolescents according to ESPGHAN for diagnosis of celiac disease","volume":"71","author":"Kabatova","year":"2017","journal-title":"Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib133","first-page":"323","article-title":"Assessment of serum antibodies against gliadin, endomysium and tissue transglutaminase in diagnosis of celiac disease in children","volume":"10","author":"Iwa\u0144czak","year":"2003","journal-title":"Gastroenterol Pol"},{"key":"key2022103115415165_ref1-bib134","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12098-017-2323-3","article-title":"Correlation of tissue transglutaminase with modified Marsh grading in celiac disease: a prospective cohort study","volume":"84","author":"Jora","year":"2017","journal-title":"Indian J Pediatr"},{"key":"key2022103115415165_ref1-bib135","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.3390\/medsci4040020","article-title":"Evaluation of multiple diagnostic indicators in comparison to the intestinal biopsy as the golden standard in diagnosing celiac disease in children","volume":"4","author":"Holl\u00e9n","year":"2016","journal-title":"Med Sci"},{"key":"key2022103115415165_ref1-bib136","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10620-011-1857-x","article-title":"Celiac disease screening assays for children younger than 3 years of age: the performance of three serological tests","volume":"57","author":"Hojsak","year":"2012","journal-title":"Dig Dis Sci"},{"key":"key2022103115415165_ref1-bib137","first-page":"e63","article-title":"Diagnostic value of HLA DQ2\/DQ8 and antitransglutaminase antibodies for the diagnosis of coeliac disease: is jejunal biopsy still mandatory?","volume":"44","author":"Clouzeau","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib138","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3109\/00365513.2015.1137348","article-title":"Simultaneous detection of IgA and IgG antibodies against tissue transglutaminase: the preferred pre-biopsy test in childhood celiac disease","volume":"76","author":"Dahlbom","year":"2016","journal-title":"Scand J Clin Lab Invest"},{"key":"key2022103115415165_ref1-bib139","doi-asserted-by":"publisher","first-page":"e1696","DOI":"10.1542\/peds.2006-0604","article-title":"Clinical value of immunoglobulin A antitransglutaminase assay in the diagnosis of celiac disease","volume":"118","author":"Diamanti","year":"2006","journal-title":"Pediatrics"},{"key":"key2022103115415165_ref1-bib140","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.cgh.2007.01.003","article-title":"Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease","volume":"5","author":"Donaldson","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib141","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/ajg.2015.87","article-title":"Evaluation of the ESPGHAN celiac guidelines in a North American pediatric population","volume":"110","author":"Gidrewicz","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"key2022103115415165_ref1-bib142","first-page":"263","article-title":"Accuracy of anti-tissue transglutaminase IgA antibody in the diagnosis of paediatric celiac disease","volume":"26","author":"Hashmi","year":"2016","journal-title":"J Coll Physicians Surg Pak"},{"key":"key2022103115415165_ref1-bib143","first-page":"S596","article-title":"Aeskulisa and H-TTG\/DGP screen for celiac disease diagnosis","volume":"49","author":"Bozzato","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"key2022103115415165_ref1-bib144","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.1542\/peds.107.1.e8","article-title":"Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients","volume":"107","author":"Chan","year":"2001","journal-title":"Pediatrics"},{"key":"key2022103115415165_ref1-bib145","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/MPG.0000000000002065","article-title":"Prospective evaluation of the ESPGHAN guidelines for diagnosis of celiac disease in New Zealand children","volume":"67","author":"Bishop","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib146","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1542\/peds.2004-1392","article-title":"Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations?","volume":"115","author":"Barker","year":"2005","journal-title":"Pediatrics"},{"key":"key2022103115415165_ref1-bib147","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jcla.1012","article-title":"Role of anti-transglutaminase (anti-tTG), anti-gliadin, and anti-endomysium serum antibodies in diagnosing celiac disease: a comparison of four different commercial kits for anti-tTG determination","volume":"15","author":"Basso","year":"2001","journal-title":"J Clin Lab Anal"},{"key":"key2022103115415165_ref1-bib148","first-page":"S704","article-title":"Evaluation of intraepithelial duodenal subsets, marsh pathological grades, and anti transglutaminase antibodies in diagnosis of celiac disease in a paediatric population","volume":"39","author":"Alonso","year":"2009","journal-title":"Eur J Immunol"},{"key":"key2022103115415165_ref1-bib149","doi-asserted-by":"publisher","first-page":"S785","DOI":"10.14309\/00000434-201210001-01930","article-title":"Is small intestinal biopsy always necessary to diagnose celiac disease in children?","volume":"107","author":"Ali","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"key2022103115415165_ref1-bib150","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/j.1600-0463.2009.02541.x","article-title":"Serologic screening for celiac disease in children: a comparison between established assays and tests with deamidated gliadin-derived peptides plus conjugates for both IgA and IgG antibodies","volume":"117","author":"Aberg","year":"2009","journal-title":"APMIS"},{"key":"key2022103115415165_ref1-bib151","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/pr.2011.1000","article-title":"The diagnostic value of serum IGG-antigliadin, IGA anti-endomysial and IGA anti-tissue transglutaminase antibodies for pediatric celiac disease","volume":"70","author":"Abdollahi","year":"2011","journal-title":"Pediatr Res"},{"key":"key2022103115415165_ref1-bib152","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1177\/000456320003700406","article-title":"Cost-effective strategy for the serological investigation of coeliac disease","volume":"37","author":"Bowron","year":"2000","journal-title":"Ann Clin Biochem"},{"key":"key2022103115415165_ref1-bib153","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1136\/gut.35.6.771","article-title":"Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values","volume":"35","author":"Corrao","year":"1994","journal-title":"Gut"},{"key":"key2022103115415165_ref1-bib154","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1155\/1997\/813148","article-title":"Evaluation of the endomysial antibody for celiac disease: operating properties and associated cost implications in clinical practice","volume":"11","author":"Atkinson","year":"1997","journal-title":"Can J Gastroenterol"},{"key":"key2022103115415165_ref1-bib155","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00042737-199706000-00002","article-title":"Association between serum levels of total IgA and IgA class endomysial and antigliadin antibodies: implications for coeliac disease screening","volume":"9","author":"Dickey","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib156","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/00042737-199811000-00004","article-title":"Diagnosis of gluten-sensitive enteropathy: is exclusive reliance on histology appropriate?","volume":"10","author":"Feighery","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib157","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/01268031-200335010-00010","article-title":"IgA class anti-endomysial and anti-tissue transglutaminase antibodies in relation to duodenal mucosa changes in coeliac disease","volume":"35","author":"Kotze","year":"2003","journal-title":"Pathology"},{"key":"key2022103115415165_ref1-bib158","doi-asserted-by":"publisher","first-page":"A160","DOI":"10.1136\/gutjnl-2018-BSGAbstracts.318","article-title":"Gluten free diet adherence assessment using CDAT and BIAGI questionnaires in patients with coeliac disease","volume":"67","author":"Lau","year":"2018","journal-title":"Gut"},{"key":"key2022103115415165_ref1-bib159","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1136\/bmj.303.6811.1163","article-title":"Predictive value for coeliac disease of antibodies to gliadin, endomysium, and jejunum in patients attending for jejunal biopsy","volume":"303","author":"McMillan","year":"1991","journal-title":"BMJ"},{"key":"key2022103115415165_ref1-bib160","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.gie.2014.02.009","article-title":"Point-of-care testing for celiac disease has a low sensitivity in endoscopy","volume":"80","author":"Mooney","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"key2022103115415165_ref1-bib161","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF02208588","article-title":"Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies?","volume":"41","author":"Valdimarsson","year":"1996","journal-title":"Dig Dis Sci"},{"key":"key2022103115415165_ref1-bib162","first-page":"394","article-title":"Screening for celiac disease: a prospective study on the value of noninvasive tests","volume":"90","author":"Vogelsang","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"key2022103115415165_ref1-bib163","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/01.mpg.0000172261.24115.29","article-title":"Celiac disease with mild to moderate histologic changes is a common cause of chronic diarrhea in Indian children","volume":"41","author":"Bhatnagar","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib164","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-94-009-1850-4_16","volume-title":"Inflammatory Bowel Disease and Coeliac Disease in Children","author":"B\u00fcrgin-Wolff","year":"1990"},{"key":"key2022103115415165_ref1-bib165","first-page":"309","article-title":"Predictive value of antigliadin, antireticulin, and antiendomysium antibodies in the diagnosis of gluten-associated enteropathy","volume":"53","author":"Camarero","year":"1997","journal-title":"Rev Esp Pediatr"},{"key":"key2022103115415165_ref1-bib166","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/00005176-199808000-00012","article-title":"Further studies of anti-endomysium and anti-gliadin antibodies in patients with suspected celiac disease","volume":"27","author":"Del Rosario","year":"1998","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib167","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.3748\/wjg.v11.i24.3762","article-title":"Comparison of six human anti-transglutaminase ELISA-tests in the diagnosis of celiac disease in the Saharawi population","volume":"11","author":"Fern\u00e1ndez","year":"2005","journal-title":"World J Gastroenterol"},{"key":"key2022103115415165_ref1-bib168","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/00005176-200110000-00013","article-title":"Antiendomysial antibody test reliability in children with frequent diarrhea and malnutrition: is it celiac disease?","volume":"33","author":"Gandolfi","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib169","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1651-2227.1995.tb13631.x","article-title":"Anti-endomysium and anti-gliadin antibodies as serological markers for coeliac disease in childhood: a clinical study to develop a practical routine","volume":"84","author":"Grodzinsky","year":"1995","journal-title":"Acta Paediatr"},{"key":"key2022103115415165_ref1-bib170","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3109\/00365529409096837","article-title":"Endomysium and gliadin IgA antibodies in children with coeliac disease","volume":"29","author":"Lindquist","year":"1994","journal-title":"Scand J Gastroenterol"},{"key":"key2022103115415165_ref1-bib171","first-page":"55","article-title":"Autoantibodies: utility in coeliac disease. a study in Misiones province","volume":"32","author":"Mendez","year":"1998","journal-title":"Acta Bioquim Clin Latinoam"},{"key":"key2022103115415165_ref1-bib172","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1542\/peds.104.1.75","article-title":"Comparative analysis of serologic screening tests for the initial diagnosis of celiac disease","volume":"104","author":"Russo","year":"1999","journal-title":"Pediatrics"},{"key":"key2022103115415165_ref1-bib173","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1157\/13074614","article-title":"Serological and genetic markers in the diagnosis and follow-up of coeliac disease","volume":"62","author":"Vargas P\u00e9rez","year":"2005","journal-title":"An Pediatr"},{"key":"key2022103115415165_ref1-bib174","first-page":"639","article-title":"IgA endomysium antibodies. Detection in children with celiac disease","volume":"140","author":"Wildfang","year":"1992","journal-title":"Monatsschr Kinderheilkd"},{"key":"key2022103115415165_ref1-bib175","doi-asserted-by":"publisher","first-page":"A26","DOI":"10.1136\/gutjnl-2013-304907.059","article-title":"Does IGA tissue transglutaminase antibody levels correlate with histological findings of coeliac disease (CD)?","volume":"62","author":"Kurien","year":"2013","journal-title":"Gut"},{"key":"key2022103115415165_ref1-bib176","first-page":"A435","article-title":"Point of care testing for adult coeliac disease: a potential role in endoscopy","volume":"2","author":"Mooney","year":"2014","journal-title":"United European Gastroenterol J"},{"key":"key2022103115415165_ref1-bib177","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MPG.0b013e3181b477a6","article-title":"Screening detects a high proportion of celiac disease in young HLA-genotyped children","volume":"50","author":"Bj\u00f6rck","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib178","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1056\/NEJMoa021687","article-title":"Prevalence of celiac disease among children in Finland","volume":"348","author":"M\u00e4ki","year":"2003","journal-title":"N Engl J Med"},{"key":"key2022103115415165_ref1-bib179","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/MPG.0b013e31829ef65d","article-title":"Transglutaminase IgA antibodies in a celiac disease mass screening and the role of HLA-DQ genotyping and endomysial antibodies in sequential testing","volume":"57","author":"Sandstr\u00f6m","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib180","doi-asserted-by":"publisher","first-page":"e20183933","DOI":"10.1542\/peds.2018-3933","article-title":"Celiac disease autoimmunity and emotional and behavioral problems in childhood","volume":"144","author":"Wahab","year":"2019","journal-title":"Pediatrics"},{"key":"key2022103115415165_ref1-bib181","doi-asserted-by":"publisher","first-page":"e485","DOI":"10.1111\/apa.13533","article-title":"Generation R birth cohort study shows that specific enamel defects were not associated with elevated serum transglutaminase type 2 antibodies","volume":"105","author":"Beth","year":"2016","journal-title":"Acta Paediatr"},{"key":"key2022103115415165_ref1-bib182","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.cgh.2014.09.032","article-title":"Growth trajectories and bone mineral density in anti-tissue transglutaminase antibody-positive children: the Generation R Study","volume":"13","author":"Jansen","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib183","volume-title":"Coeliac Disease Survey, Video 1","author":"National Institute for Health and Care Research Applied Research Collaboration West"},{"key":"key2022103115415165_ref1-bib184","volume-title":"Coeliac Disease Survey, Video 2","author":"National Institute for Health and Care Research Applied Research Collaboration West"},{"key":"key2022103115415165_ref1-bib185","volume-title":"Coeliac Disease Survey, Video 3","author":"National Institute for Health and Care Research Applied Research Collaboration West"},{"key":"key2022103115415165_ref1-bib186","volume-title":"ISO\/IEC 27001: Information Security Management","author":"International Organization for Standardization"},{"key":"key2022103115415165_ref1-bib187","volume-title":"Guide to the UK General Data Protection Regulation (UK GDPR)","author":"Information Commissioner\u2019s Office"},{"key":"key2022103115415165_ref1-bib188","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.1365-2036.2009.04220.x","article-title":"The development and validation of a new coeliac disease quality of life survey (CD-QOL)","volume":"31","author":"Dorn","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"key2022103115415165_ref1-bib189","volume-title":"Scottish Index of Multiple Deprivation 2020v2 Postcode Lookup File","author":"Scottish Government"},{"key":"key2022103115415165_ref1-bib190","volume-title":"Welsh Index of Multiple Deprivation (WIMD) Index Guidance, Technical Information and Background Documentation","author":"Welsh Government"},{"key":"key2022103115415165_ref1-bib191","volume-title":"NI Multiple Deprivation Measures","author":"Northern Ireland Statistics and Research Agency"},{"key":"key2022103115415165_ref1-bib192","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","year":"2005","journal-title":"Qual Health Res"},{"key":"key2022103115415165_ref1-bib193","unstructured":"National Institute for Health and Care Excellence (NICE). Coeliac Disease. Full Health Economics Report. London: NICE; 2015."},{"key":"key2022103115415165_ref1-bib194","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10198-012-0441-4","article-title":"Targeted screening for coeliac disease among irritable bowel syndrome patients: analysis of cost-effectiveness and value of information","volume":"14","author":"Mohseninejad","year":"2013","journal-title":"Eur J Health Econ"},{"key":"key2022103115415165_ref1-bib195","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1023\/a:1012396408370","article-title":"Diagnostic approach to a patient with suspected celiac disease: a cost analysis","volume":"46","author":"Harewood","year":"2001","journal-title":"Dig Dis Sci"},{"key":"key2022103115415165_ref1-bib196","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/j.1365-2036.2004.01958.x","article-title":"Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis","volume":"19","author":"Mein","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"key2022103115415165_ref1-bib197","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1053\/j.gastro.2004.03.012","article-title":"Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis","volume":"126","author":"Spiegel","year":"2004","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib198","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/0272989X06289012","article-title":"Cost-effectiveness analysis of screening for celiac disease in the adult population","volume":"26","author":"Shamir","year":"2006","journal-title":"Med Decis Making"},{"key":"key2022103115415165_ref1-bib199","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1542\/peds.2005-2123","article-title":"Screening for celiac disease in asymptomatic children with Down syndrome: cost-effectiveness of preventing lymphoma","volume":"118","author":"Swigonski","year":"2006","journal-title":"Pediatrics"},{"key":"key2022103115415165_ref1-bib200","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s10620-007-9939-5","article-title":"Cost-effectiveness analysis of strategies for diagnosing celiac disease","volume":"53","author":"Dorn","year":"2008","journal-title":"Dig Dis Sci"},{"key":"key2022103115415165_ref1-bib201","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/MCG.0b013e318187311d","article-title":"Genetic testing before serologic screening in relatives of patients with celiac disease as a cost containment method","volume":"43","author":"Chang","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"key2022103115415165_ref1-bib202","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/j.1365-2036.2010.04242.x","article-title":"Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet","volume":"31","author":"Hershcovici","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"key2022103115415165_ref1-bib203","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cgh.2012.12.037","article-title":"Cost-effectiveness of universal serologic screening to prevent nontraumatic hip and vertebral fractures in patients with celiac disease","volume":"11","author":"Park","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib204","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/BF01623315","article-title":"Cost-effectiveness of fracture prevention in established osteoporosis","volume":"5","author":"J\u00f6nsson","year":"1995","journal-title":"Osteoporos Int"},{"key":"key2022103115415165_ref1-bib205","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1359\/jbmr.2000.15.7.1384","article-title":"Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures","volume":"15","author":"Oleksik","year":"2009","journal-title":"J Bone Miner Res"},{"key":"key2022103115415165_ref1-bib206","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cgh.2015.03.022","article-title":"Cost effectiveness of routine duodenal biopsy analysis for celiac disease during endoscopy for gastroesophageal reflux","volume":"13","author":"Yang","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib207","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.3748\/wjg.v22.i34.7813","article-title":"Cost effectiveness of routine duodenal biopsies in iron deficiency anemia","volume":"22","author":"Broide","year":"2016","journal-title":"World J Gastroenterol"},{"key":"key2022103115415165_ref1-bib208","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jval.2012.06.014","article-title":"State-transition modelling: a report of the ISPOR-SMDM Modelling Good Research Practices Task Force-3","volume":"15","author":"Siebert","year":"2012","journal-title":"Value Health"},{"key":"key2022103115415165_ref1-bib209","volume-title":"Ongoing Symptoms and Complications","author":"Coeliac"},{"issue":"29","key":"key2022103115415165_ref1-bib210","doi-asserted-by":"publisher","DOI":"10.3310\/hta21290","article-title":"Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis","volume":"21","author":"Welton","year":"2017","journal-title":"Health Technol Assess"},{"key":"key2022103115415165_ref1-bib211","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40985-018-0093-8","article-title":"Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis","volume":"39","author":"Iragorri","year":"2018","journal-title":"Public Health Rev"},{"key":"key2022103115415165_ref1-bib212","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"key2022103115415165_ref1-bib213","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1159\/000489394","article-title":"Absence of complications after endoscopic mucosal biopsy","volume":"36","author":"Johnson","year":"2018","journal-title":"Dig Dis"},{"key":"key2022103115415165_ref1-bib214","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2036.2009.04053.x","article-title":"Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease","volume":"30","author":"Hall","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"key2022103115415165_ref1-bib215","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1017\/S002966511800277X","article-title":"Identifying and improving adherence to the gluten-free diet in people with coeliac disease","volume":"78","author":"Muhammad","year":"2019","journal-title":"Proc Nutr Soc"},{"key":"key2022103115415165_ref1-bib216","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1053\/j.gastro.2014.08.025","article-title":"Women with celiac disease present with fertility problems no more often than women in the general population","volume":"147","author":"Dhalwani","year":"2014","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib217","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1053\/j.gastro.2005.02.017","article-title":"Fertility and pregnancy-related events in women with celiac disease: a population-based cohort study","volume":"128","author":"Tata","year":"2005","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib218","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1136\/gut.2010.219030","article-title":"A nationwide population-based study to determine whether coeliac disease is associated with infertility","volume":"59","author":"Zugna","year":"2010","journal-title":"Gut"},{"key":"key2022103115415165_ref1-bib219","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.3109\/00365521.2011.615858","article-title":"Screening for unrecognized coeliac disease in subfertile couples","volume":"46","author":"Hogen Esch","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"key2022103115415165_ref1-bib220","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/apt.15109","article-title":"Serology-based criteria for adult coeliac disease have excellent accuracy across the range of pre-test probabilities","volume":"49","author":"Fuchs","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"key2022103115415165_ref1-bib221","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1365-2036.2008.03609.x","article-title":"Coeliac disease: a biopsy is not always necessary for diagnosis","volume":"27","author":"Hill","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"key2022103115415165_ref1-bib222","volume-title":"National Schedule of NHS Costs 2019","author":"NHS"},{"key":"key2022103115415165_ref1-bib223","volume-title":"Unit Costs of Health and Social Care 2020","author":"Curtis","year":"2020"},{"key":"key2022103115415165_ref1-bib224","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10198-016-0775-4","article-title":"Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort","volume":"18","author":"Wang","year":"2017","journal-title":"Eur J Health Econ"},{"key":"key2022103115415165_ref1-bib225","volume-title":"Payment by Results in the NHS: Tariff for 2013 to 2014","author":"Department of Health and Social Care","year":"2013"},{"key":"key2022103115415165_ref1-bib226","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bone.2016.03.006","article-title":"Epidemiology of fractures in the United Kingdom 1988\u20132012: variation with age, sex, geography, ethnicity and socioeconomic status","volume":"87","author":"Curtis","year":"2016","journal-title":"Bone"},{"key":"key2022103115415165_ref1-bib227","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00198-015-3277-9","article-title":"REFReSH study group. Impact of hip fracture on hospital care costs: a population-based study","volume":"27","author":"Leal","year":"2016","journal-title":"Osteoporos Int"},{"key":"key2022103115415165_ref1-bib228","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s001980050107","article-title":"The cost of treating osteoporotic fractures in the United Kingdom female population","volume":"8","author":"Dolan","year":"1998","journal-title":"Osteoporos Int"},{"key":"key2022103115415165_ref1-bib229","volume-title":"Consumer Price Inflation Tables","author":"Office for National Statistics"},{"key":"key2022103115415165_ref1-bib230","doi-asserted-by":"crossref","unstructured":"Janssen B, Szende A. Population norms for the EQ-5D. In Szende A, Janssen B, Cabases J, editors. Self-Reported Population Health: An International Perspective Based on EQ-5D. Dordrecht: Springer Netherlands; 2014. pp. 19\u201330. https:\/\/doi.org\/10.1007\/978-94-007-7596-1_3","DOI":"10.1007\/978-94-007-7596-1_3"},{"key":"key2022103115415165_ref1-bib231","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12876-019-0980-6","article-title":"The impact of diagnosis on health-related quality of life in people with coeliac disease: a UK population-based longitudinal perspective","volume":"19","author":"Violato","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"key2022103115415165_ref1-bib232","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3748\/wjg.14.46","article-title":"Factors that impact health-related quality of life in adults with celiac disease: a multicenter study","volume":"14","author":"Casellas","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key2022103115415165_ref1-bib233","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s00198-014-2636-2","article-title":"A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions","volume":"25","author":"Si","year":"2014","journal-title":"Osteoporos Int"},{"key":"key2022103115415165_ref1-bib234","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00277-017-3147-y","article-title":"SMABcare study: subcutaneous monoclonal antibody in cancer care: cost\u2013consequence analysis of subcutaneous rituximab in patients with follicular lymphoma","volume":"97","author":"Fargier","year":"2018","journal-title":"Ann Hematol"},{"key":"key2022103115415165_ref1-bib235","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-2036.2006.03203.x","article-title":"Coeliac disease and the risk of fractures \u2013 a general population-based cohort study","volume":"25","author":"Ludvigsson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"key2022103115415165_ref1-bib236","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1053\/j.gastro.2010.05.041","article-title":"Morbidity and mortality among older individuals with undiagnosed celiac disease","volume":"139","author":"Godfrey","year":"2010","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib237","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-230X-7-8","article-title":"Collaborating centers of the Italian registry of the complications of coeliac disease. Delayed diagnosis of coeliac disease increases cancer risk","volume":"7","author":"Silano","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"key2022103115415165_ref1-bib238","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/MEG.0b013e3282f2a5e2","article-title":"Cancer in patients with ulcerative colitis, Crohn\u2019s disease and coeliac disease: record linkage study","volume":"20","author":"Goldacre","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib239","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2165\/00019053-200725010-00002","article-title":"Rates and probabilities in economic modelling: transformation, translation and appropriate application","volume":"25","author":"Fleurence","year":"2007","journal-title":"PharmacoEconomics"},{"key":"key2022103115415165_ref1-bib240","volume-title":"National Life Tables, United Kingdom, 1980\u20131982 to 2017\u20132019","author":"Office for National Statistics"},{"key":"key2022103115415165_ref1-bib241","unstructured":"Office for National Statistics. Cancer Survival in England: Adults Diagnosed Between 2013 and 2017 and Followed Up to 2018. Newport: Office for National Statistics; 2018."},{"key":"key2022103115415165_ref1-bib242","volume-title":"The BUGS Book : A Practical Introduction to Bayesian Analysis","author":"Lunn","year":"2013"},{"key":"key2022103115415165_ref1-bib243","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bone.2014.06.011","article-title":"Mortality in British hip fracture patients, 2000\u20132010: a population-based retrospective cohort study","volume":"66","author":"Klop","year":"2014","journal-title":"Bone"},{"key":"key2022103115415165_ref1-bib244","volume-title":"British National Formulary","author":"Joint Formulary Committee"},{"key":"key2022103115415165_ref1-bib245","volume-title":"Guide to the Methods of Technology Appraisal 2013","author":"National Institute for Health and Care Excellence"},{"key":"key2022103115415165_ref1-bib246","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s40258-021-00664-2","article-title":"Methodological note: reporting deterministic versus probabilistic results of Markov, partitioned survival and other non-linear models","volume":"19","author":"Wilson","year":"2021","journal-title":"Appl Health Econ Health Policy"},{"key":"key2022103115415165_ref1-bib247","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/archdischild-2016-312027","article-title":"Barriers to implementing the revised ESPGHAN guidelines for coeliac disease in children: a cross-sectional survey of coeliac screen reporting in laboratories in England","volume":"102","author":"Paul","year":"2017","journal-title":"Arch Dis Child"},{"key":"key2022103115415165_ref1-bib248","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/j.1524-4733.2008.00358.x","article-title":"Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI)","volume":"11","author":"Barton","year":"2008","journal-title":"Value Health"},{"key":"key2022103115415165_ref1-bib249","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jval.2020.01.001","article-title":"Value of information analysis for research decisions \u2013 an introduction: report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force","volume":"23","author":"Fenwick","year":"2020","journal-title":"Value Health"},{"key":"key2022103115415165_ref1-bib250","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jval.2020.01.004","article-title":"Value of information analytical methods: report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force","volume":"23","author":"Rothery","year":"2020","journal-title":"Value Health"},{"key":"key2022103115415165_ref1-bib251","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1177\/0962280211419832","article-title":"Probabilistic sensitivity analysis in health economics","volume":"24","author":"Baio","year":"2015","journal-title":"Stat Methods Med Res"},{"key":"key2022103115415165_ref1-bib252","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/0272989X13505910","article-title":"Estimating multiparameter partial expected value of perfect information from a probabilistic sensitivity analysis sample: a nonparametric regression approach","volume":"34","author":"Strong","year":"2014","journal-title":"Med Decis Making"},{"key":"key2022103115415165_ref1-bib253","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1177\/0272989X15575286","article-title":"Estimating the expected value of sample information using the probabilistic sensitivity analysis sample: a fast, nonparametric regression-based method","volume":"35","author":"Strong","year":"2015","journal-title":"Med Decis Making"},{"key":"key2022103115415165_ref1-bib254","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/0272989X211026305","article-title":"Multilevel and quasi Monte Carlo methods for the calculation of the expected value of partial perfect information","volume":"42","author":"Fang","year":"2022","journal-title":"Med Decis Making"},{"key":"key2022103115415165_ref1-bib255","volume-title":"Population Estimates","author":"Office for National Statistics"},{"key":"key2022103115415165_ref1-bib256","volume-title":"UK Population by Ethnicity: Age Groups","author":"UK Government"},{"key":"key2022103115415165_ref1-bib257","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jval.2019.01.003","article-title":"R You still using Excel? The advantages of modern software tools for health technology assessment","volume":"22","author":"Incerti","year":"2019","journal-title":"Value Health"},{"key":"key2022103115415165_ref1-bib258","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/CCID.S69127","article-title":"The diagnosis and treatment of dermatitis herpetiformis","volume":"8","author":"Antiga","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"key2022103115415165_ref1-bib259","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jval.2020.02.010","article-title":"Computing the expected value of sample information efficiently: practical guidance and recommendations for four model-based methods","volume":"23","author":"Kunst","year":"2020","journal-title":"Value Health"},{"key":"key2022103115415165_ref1-bib260","doi-asserted-by":"publisher","first-page":"e019637","DOI":"10.1136\/bmjopen-2017-019637","article-title":"Identifying clinical features in primary care electronic health record studies: methods for codelist development","volume":"7","author":"Watson","year":"2017","journal-title":"BMJ Open"},{"key":"key2022103115415165_ref1-bib261","volume-title":"NICE DSU Technical Support Document 15: Cost-Effectiveness Modelling Using Patient-Level Simulation","author":"Davis","year":"2014"},{"key":"key2022103115415165_ref1-bib262","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1038\/ajg.2010.153","article-title":"How patchy is patchy villous atrophy? Distribution pattern of histological lesions in the duodenum of children with celiac disease","volume":"105","author":"Ravelli","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"key2022103115415165_ref1-bib263","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.gie.2011.03.1236","article-title":"Adherence to biopsy guidelines increases celiac disease diagnosis","volume":"74","author":"Lebwohl","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"key2022103115415165_ref1-bib264","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11892-014-0517-x","article-title":"Type 1 diabetes and celiac disease: clinical overlap and new insights into disease pathogenesis","volume":"14","author":"Cohn","year":"2014","journal-title":"Curr Diab Rep"},{"key":"key2022103115415165_ref1-bib265","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ajg.2016.466","article-title":"Screening for celiac disease in irritable bowel syndrome: an updated systematic review and meta-analysis","volume":"112","author":"Irvine","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"key2022103115415165_ref1-bib266","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00415-018-9025-2","article-title":"Gluten sensitivity and epilepsy: a systematic review","volume":"266","author":"Julian","year":"2019","journal-title":"J Neurol"},{"key":"key2022103115415165_ref1-bib267","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/MCG.0000000000000285","article-title":"Celiac disease in women with infertility: a meta-analysis","volume":"50","author":"Singh","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"key2022103115415165_ref1-bib268","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1089\/thy.2016.0108","article-title":"Prevalence of celiac disease in patients with autoimmune thyroid disease: a meta-analysis","volume":"26","author":"Roy","year":"2016","journal-title":"Thyroid"},{"key":"key2022103115415165_ref1-bib269","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1365-2036.2011.04685.x","article-title":"Meta-analysis: coeliac disease and hypertransaminasaemia","volume":"34","author":"Sainsbury","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"key2022103115415165_ref1-bib270","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/apt.14911","article-title":"Systematic review with meta-analysis: the prevalence of coeliac disease in patients with osteoporosis","volume":"48","author":"Laszkowska","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"key2022103115415165_ref1-bib271","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.jaad.2019.11.039","article-title":"Association between psoriasis and celiac disease: a systematic review and meta-analysis","volume":"82","author":"Acharya","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"key2022103115415165_ref1-bib272","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1053\/j.gastro.2020.05.016","article-title":"Association between inflammatory bowel diseases and celiac disease: a systematic review and meta-analysis","volume":"159","author":"Pinto-Sanchez","year":"2020","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib273","doi-asserted-by":"publisher","first-page":"E1445","DOI":"10.3390\/nu10101445","article-title":"Headache associated with coeliac disease: a systematic review and meta-analysis","volume":"10","author":"Zis","year":"2018","journal-title":"Nutrients"},{"key":"key2022103115415165_ref1-bib274","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1572-0241.2003.07300.x","article-title":"Association between migraine and celiac disease: results from a preliminary case\u2013control and therapeutic study","volume":"98","author":"Gabrielli","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"key2022103115415165_ref1-bib275","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/ajg.2015.296","article-title":"Risk of celiac disease in the first- and second-degree relatives of patients with celiac disease: a systematic review and meta-analysis","volume":"110","author":"Singh","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"key2022103115415165_ref1-bib276","doi-asserted-by":"publisher","first-page":"e0121908","DOI":"10.1371\/journal.pone.0121908","article-title":"Prevalence of serum celiac antibodies in a multiracial Asian population \u2013 a first study in the young Asian adult population of Malaysia","volume":"10","author":"Yap","year":"2015","journal-title":"PLOS ONE"},{"key":"key2022103115415165_ref1-bib277","doi-asserted-by":"publisher","first-page":"15830","DOI":"10.3748\/wjg.v20.i42.15830","article-title":"Seroprevalence of celiac disease among United Arab Emirates healthy adult nationals: a gender disparity","volume":"20","author":"Abu-Zeid","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key2022103115415165_ref1-bib278","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.05.040","article-title":"Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease","volume":"137","author":"Romanos","year":"2009","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib279","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/gutjnl-2012-304110","article-title":"Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants","volume":"63","author":"Romanos","year":"2014","journal-title":"Gut"},{"key":"key2022103115415165_ref1-bib280","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.cir.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"key2022103115415165_ref1-bib281","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.3399\/bjgp13X660733","article-title":"Symptoms and risk factors to identify women with suspected cancer in primary care: derivation and validation of an algorithm","volume":"63","author":"Hippisley-Cox","year":"2013","journal-title":"Br J Gen Pract"},{"key":"key2022103115415165_ref1-bib282","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.3399\/bjgp13X660724","article-title":"Symptoms and risk factors to identify men with suspected cancer in primary care: derivation and validation of an algorithm","volume":"63","author":"Hippisley-Cox","year":"2013","journal-title":"Br J Gen Pract"},{"key":"key2022103115415165_ref1-bib283","doi-asserted-by":"publisher","first-page":"423","DOI":"10.17235\/reed.2015.3758\/2015","article-title":"The potential usefulness of human leukocyte antigen typing for celiac disease screening: a systematic review and meta-analysis","volume":"107","author":"D\u00edaz-Redondo","year":"2015","journal-title":"Rev Esp Enferm Dig"},{"key":"key2022103115415165_ref1-bib284","volume-title":"Criteria for Appraising the Viability, Effectiveness and Appropriateness of a Screening Programme","author":"UK National Screening Committee"},{"key":"key2022103115415165_ref1-bib285","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1053\/j.gastro.2017.11.006","article-title":"HLA-DQ-gluten tetramer blood test accurately identifies patients with and without celiac disease in absence of gluten consumption","volume":"154","author":"Sarna","year":"2018","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib286","first-page":"A255","article-title":"Association of adult coeliac disease with surgical abdominal pain: a case controlled study in patients referred to secondary care","volume":"128","author":"Hopper","year":"2005","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib287","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/01.sla.0000171301.35513.cf","article-title":"Association of adult celiac disease with surgical abdominal pain: a case\u2013control study in patients referred to secondary care","volume":"242","author":"Sanders","year":"2005","journal-title":"Ann Surg"},{"key":"key2022103115415165_ref1-bib288","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1016\/j.cgh.2015.05.014","article-title":"Evidence against routine testing of patients with functional gastrointestinal disorders for celiac disease: a population-based study","volume":"13","author":"Choung","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib289","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/01.meg.0000250586.61232.a3","article-title":"High prevalence of celiac disease in Brazilian blood donor volunteers based on screening by IgA antitissue transglutaminase antibody","volume":"19","author":"Oliveira","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib290","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/apt.14625","article-title":"Natural history and clinical detection of undiagnosed coeliac disease in a North American community","volume":"47","author":"Hujoel","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"key2022103115415165_ref1-bib291","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/00005176-200109000-00004","article-title":"Screening for celiac disease in children with recurrent abdominal pain","volume":"33","author":"Fitzpatrick","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib292","first-page":"314","article-title":"The evaluation of factors and symptoms related to celiac disease in Turkish children","volume":"46","author":"Dalgic","year":"2011","journal-title":"Turk Pediatri Arsivi"},{"key":"key2022103115415165_ref1-bib293","doi-asserted-by":"publisher","first-page":"180","DOI":"10.14309\/ajg.0000000000000751","article-title":"Mass screening for celiac disease: the Autoimmunity Screening for Kids study","volume":"116","author":"Stahl","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"key2022103115415165_ref1-bib294","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1590\/s0004-2803.2017v54n1-07","article-title":"Celiac disease prevalence is not increased in patients with functional dyspepsia","volume":"54","author":"Lasa","year":"2017","journal-title":"Arq Gastroenterol"},{"key":"key2022103115415165_ref1-bib295","first-page":"A257","article-title":"Endoscopic markers for screening of villous atrophy in patients with dyspepsia or high-risk of celiac disease: a prospective controlled study","volume":"128","author":"Lecleire","year":"2005","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib296","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/ajg.2011.21","article-title":"Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms","volume":"106","author":"Katz","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"key2022103115415165_ref1-bib297","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085(19)39262-5","article-title":"Prevalence of celiac disease (CD) in subjects with dyspeptic symptoms: a case\u2013control study","volume":"156","author":"Lara-Carmona","year":"2019","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib298","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/00365520600789974","article-title":"Undiagnosed coeliac disease and nutritional deficiencies in adults screened in primary health care","volume":"42","author":"Tikkakoski","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"key2022103115415165_ref1-bib299","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3109\/00365521.2013.792389","article-title":"Celiac disease, eosinophilic esophagitis and gastroesophageal reflux disease, an adult population-based study","volume":"48","author":"Ludvigsson","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"key2022103115415165_ref1-bib300","doi-asserted-by":"publisher","first-page":"476","DOI":"10.4065\/79.4.476","article-title":"Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case\u2013control study","volume":"79","author":"Locke","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"key2022103115415165_ref1-bib301","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/01.meg.0000059104.41030.1c","article-title":"Human recombinant anti-transglutaminase antibody testing is useful in the diagnosis of silent coeliac disease in a selected group of at-risk patients","volume":"15","author":"Vivas","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib302","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1749-6632.2009.04755.x","article-title":"The incidence of celiac disease antibodies in plasma specimens with low hemoglobin levels","volume":"1173","author":"Alexander","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"key2022103115415165_ref1-bib303","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12664-015-0586-z","article-title":"Prevalence of celiac disease in adult patients with iron-deficiency anemia of obscure origin in Kashmir (India)","volume":"34","author":"Javid","year":"2015","journal-title":"Indian J Gastroenterol"},{"key":"key2022103115415165_ref1-bib304","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4318\/tjg.2009.0024","article-title":"Celiac disease prevalence in patients with iron deficiency anemia of obscure origin","volume":"20","author":"U\u00e7arda\u011f","year":"2009","journal-title":"Turk J Gastroenterol"},{"key":"key2022103115415165_ref1-bib305","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.rgmxen.2016.12.004","article-title":"Iron-deficiency anemia as a subclinical celiac disease presentation in an Argentinian population","volume":"82","author":"Lasa","year":"2017","journal-title":"Rev Gastroenterol Mex"},{"key":"key2022103115415165_ref1-bib306","first-page":"282","article-title":"Prevalence of gluten sensitive enteropathy antibodies in restless legs syndrome","volume":"111","author":"Cikrikcioglu","year":"2011","journal-title":"Acta Neurol Belg"},{"key":"key2022103115415165_ref1-bib307","doi-asserted-by":"publisher","first-page":"31","DOI":"10.20452\/pamw.15094","article-title":"Antibodies involved in the development of pernicious anemia and other autoimmune diseases","volume":"130","author":"Morawiec-Szymonik","year":"2020","journal-title":"Pol Arch Intern Med"},{"key":"key2022103115415165_ref1-bib308","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/00004836-200209000-00006","article-title":"A controlled, prospective screening study of celiac disease presenting as iron deficiency anemia","volume":"35","author":"Ransford","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"key2022103115415165_ref1-bib309","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/00042737-200304000-00012","article-title":"A primary care cross-sectional study of undiagnosed adult coeliac disease","volume":"15","author":"Sanders","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib310","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/gut.53.1.149","article-title":"Undiagnosed coeliac disease does not appear to be associated with unfavourable outcome of pregnancy","volume":"53","author":"Greco","year":"2004","journal-title":"Gut"},{"key":"key2022103115415165_ref1-bib311","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/j.1651-2227.2005.tb01964.x","article-title":"The prevalence of coeliac disease as detected by screening in children with iron deficiency anaemia","volume":"94","author":"Kalayci","year":"2005","journal-title":"Acta Paediatr"},{"key":"key2022103115415165_ref1-bib312","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1590\/s0004-2803.201800000-15","article-title":"Association of potential celiac disease and refractory iron deficiency anemia in children and adolescents","volume":"55","author":"Shahriari","year":"2018","journal-title":"Arq Gastroenterol"},{"key":"key2022103115415165_ref1-bib313","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13312-018-1223-6","article-title":"Celiac disease in children with moderate-to-severe iron-deficiency anemia","volume":"55","author":"Narang","year":"2018","journal-title":"Indian Pediatr"},{"key":"key2022103115415165_ref1-bib314","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/01.mcg.0000174026.26838.56","article-title":"Prevalence of celiac disease in Turkish children","volume":"39","author":"Ertekin","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"key2022103115415165_ref1-bib315","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1023\/b:ddas.0000007875.72256.e8","article-title":"IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis","volume":"48","author":"Bizzaro","year":"2003","journal-title":"Dig Dis Sci"},{"key":"key2022103115415165_ref1-bib316","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/09674845.2003.11783671","article-title":"Anti-transglutaminase antibodies and the serological diagnosis of coeliac disease","volume":"60","author":"Feighery","year":"2003","journal-title":"Br J Biomed Sci"},{"key":"key2022103115415165_ref1-bib317","first-page":"163","article-title":"Rheumatoid arthritis and anti-endomysial antibodies","volume":"32","author":"Nisihara","year":"2007","journal-title":"Acta Reumatol Port"},{"key":"key2022103115415165_ref1-bib318","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1373\/clinchem.2003.023234","article-title":"Anti-tissue transglutaminase antibodies in arthritic patients: a disease-specific finding?","volume":"49","author":"Picarelli","year":"2003","journal-title":"Clin Chem"},{"key":"key2022103115415165_ref1-bib319","first-page":"920","article-title":"Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis","volume":"31","author":"Riente","year":"2004","journal-title":"J Rheumatol"},{"key":"key2022103115415165_ref1-bib320","first-page":"2613","article-title":"Autoantibodies to tissue transglutaminase in Sj\u00f6gren\u2019s syndrome and related rheumatic diseases","volume":"30","author":"Luft","year":"2003","journal-title":"J Rheumatol"},{"key":"key2022103115415165_ref1-bib321","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/jbmr.2380","article-title":"Celiac disease autoimmunity and hip fracture risk: findings from a prospective cohort study","volume":"30","author":"Heikkil\u00e4","year":"2015","journal-title":"J Bone Miner Res"},{"key":"key2022103115415165_ref1-bib322","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1756-185X.2011.01681.x","article-title":"Asymptomatic celiac sprue in juvenile rheumatic diseases children","volume":"15","author":"Gheita","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"key2022103115415165_ref1-bib323","first-page":"222","article-title":"The frequency of the celiac disease in patients with juvenile idiopathic arthritis","volume":"64","author":"Sahin","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib324","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/archdischild-2016-311544","article-title":"HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis","volume":"102","author":"Skrabl-Baumgartner","year":"2017","journal-title":"Arch Dis Child"},{"key":"key2022103115415165_ref1-bib325","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/rheumatology\/keh531","article-title":"Thyroid function, autoimmune thyroiditis and coeliac disease in juvenile idiopathic arthritis","volume":"44","author":"Stagi","year":"2005","journal-title":"Rheumatology"},{"key":"key2022103115415165_ref1-bib326","first-page":"310","article-title":"Autoimmune endocrine disorders and coeliac disease in children and adolescents with juvenile idiopathic arthritis and rheumatic fever","volume":"31","author":"Robazzi","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"key2022103115415165_ref1-bib327","first-page":"22","article-title":"Prevalence of celiac antibodies and IgA deficiency in juvenile idiopathic arthritis","volume":"69","author":"Taneja","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"key2022103115415165_ref1-bib328","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/147323000903700127","article-title":"The significance of coeliac disease antibodies in patients with ankylosing spondylitis: a case\u2013controlled study","volume":"37","author":"To\u011frol","year":"2009","journal-title":"J Int Med Res"},{"key":"key2022103115415165_ref1-bib329","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/MPG.0b013e31827b7f64","article-title":"The celiac iceberg: characterization of the disease in primary schoolchildren","volume":"56","author":"Nenna","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib330","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3906\/sag-1502-130","article-title":"Celiac disease in children with chronic constipation","volume":"46","author":"\u00c7akir","year":"2016","journal-title":"Turk J Med Sci"},{"key":"key2022103115415165_ref1-bib331","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jpeds.2020.07.052","article-title":"Celiac disease in children with functional constipation: a school-based multicity study","volume":"227","author":"Fifi","year":"2020","journal-title":"J Pediatr"},{"key":"key2022103115415165_ref1-bib332","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1006\/clim.2000.4983","article-title":"Tissue transglutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis","volume":"98","author":"Kumar","year":"2001","journal-title":"Clin Immunol"},{"key":"key2022103115415165_ref1-bib333","doi-asserted-by":"publisher","first-page":"E136","DOI":"10.3390\/medicina55050136","article-title":"Celiac-related autoantibodies and IL-17A in Bulgarian patients with dermatitis herpetiformis: a cross-sectional study","volume":"55","author":"Velikova","year":"2019","journal-title":"Medicina"},{"key":"key2022103115415165_ref1-bib334","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1542-3565(04)00778-5","article-title":"Permeability, zonulin production, and enteropathy in dermatitis herpetiformis","volume":"3","author":"Smecuol","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib335","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/01.MPG.0000154012.10420.08","article-title":"Celiac disease in children with diarrhea is more frequent than previously suspected","volume":"40","author":"Imanzadeh","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib336","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.yebeh.2005.01.007","article-title":"Celiac disease-related antibodies in an epilepsy cohort and matched reference population","volume":"6","author":"Ranua","year":"2005","journal-title":"Epilepsy Behav"},{"key":"key2022103115415165_ref1-bib337","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.pediatrneurol.2006.11.011","article-title":"Increased prevalence of silent celiac disease among Greek epileptic children","volume":"36","author":"Mavroudi","year":"2007","journal-title":"Pediatr Neurol"},{"key":"key2022103115415165_ref1-bib338","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/08830738060210010301","article-title":"Latent and potential celiac disease in epileptic Turkish children","volume":"21","author":"Dalgi\u00e7","year":"2006","journal-title":"J Child Neurol"},{"key":"key2022103115415165_ref1-bib339","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00381-014-2387-6","article-title":"Prevalence of resistant occipital lobe epilepsy associated with celiac disease in children","volume":"30","author":"Dai","year":"2014","journal-title":"Childs Nerv Syst"},{"key":"key2022103115415165_ref1-bib340","first-page":"247","article-title":"Celiac disease prevalence in epileptic children from Serbia","volume":"54","author":"Djuri\u0107","year":"2012","journal-title":"Turk J Pediatr"},{"key":"key2022103115415165_ref1-bib341","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pediatrneurol.2009.02.009","article-title":"Celiac disease-related antibodies in Italian children with epilepsy","volume":"41","author":"Giordano","year":"2009","journal-title":"Pediatr Neurol"},{"key":"key2022103115415165_ref1-bib342","first-page":"280","article-title":"Prevalence of celiac disease in Turkish children with idiopathic epilepsy","volume":"24","author":"I\u015fikay","year":"2014","journal-title":"Iran J Pediatr"},{"key":"key2022103115415165_ref1-bib343","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.pediatrneurol.2014.01.021","article-title":"Prevalence of celiac disease in children with idiopathic epilepsy in southeast Turkey","volume":"50","author":"I\u015f\u0131kay","year":"2014","journal-title":"Pediatr Neurol"},{"key":"key2022103115415165_ref1-bib344","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0887-8994(00)00129-6","article-title":"Prevalence of celiac antibodies in children with neurologic disorders","volume":"22","author":"Lahat","year":"2000","journal-title":"Pediatr Neurol"},{"key":"key2022103115415165_ref1-bib345","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1590\/S0004-282X2003000300002","article-title":"Is the prevalence of celiac disease increased among epileptic patients?","volume":"61","author":"Pratesi","year":"2003","journal-title":"Arq Neuropsiquiatr"},{"key":"key2022103115415165_ref1-bib346","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s12664-019-00990-3","article-title":"Prevalence of thyroid autoimmunity in first-degree relatives of patients with celiac disease","volume":"38","author":"Soni","year":"2019","journal-title":"Indian J Gastroenterol"},{"key":"key2022103115415165_ref1-bib347","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085(19)37130-6","article-title":"Prevalence of celiac disease autoimmunity and associated morbid conditions in first-degree relatives of patients with celiac disease","volume":"156","author":"Choung","year":"2019","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib348","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1001\/archinte.163.3.286","article-title":"Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study","volume":"163","author":"Fasano","year":"2003","journal-title":"Arch Intern Med"},{"key":"key2022103115415165_ref1-bib349","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10620-018-5320-0","article-title":"Prevalence and clinical features of celiac disease in healthy school-aged children","volume":"64","author":"Beser","year":"2019","journal-title":"Dig Dis Sci"},{"key":"key2022103115415165_ref1-bib350","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.humimm.2006.04.009","article-title":"HLA DQA1*0501 and DQB 1*02 in Cuban celiac patients","volume":"67","author":"Cintado","year":"2006","journal-title":"Hum Immunol"},{"key":"key2022103115415165_ref1-bib351","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1590\/s0004-28032001000200004","article-title":"Antiendomysium antibodies in Brazilian patients with celiac disease and their first-degree relatives","volume":"38","author":"Kotze","year":"2001","journal-title":"Arq Gastroenterol"},{"key":"key2022103115415165_ref1-bib352","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000320451","article-title":"Ramos da Rosa Utiyama S. Serological and clinical follow-up of relatives of celiac disease patients from southern Brazil","volume":"83","author":"Nass","year":"2011","journal-title":"Digestion"},{"key":"key2022103115415165_ref1-bib353","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1590\/S0004-28032007000200014","article-title":"Serological screening of relatives of celiac disease patients: antiendomysium antibodies, anti-tissue transglutaminase or both?","volume":"44","author":"Utiyama","year":"2007","journal-title":"Arq Gastroenterol"},{"key":"key2022103115415165_ref1-bib354","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1080\/00365521.2018.1509122","article-title":"Positive IgA against transglutaminase 2 in patients with distal radius and ankle fractures compared to community-based controls","volume":"53","author":"Hjelle","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"key2022103115415165_ref1-bib355","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1136\/annrheumdis-2014-eular.1238","article-title":"Celiac disease and positive IgA tissue transglutaminase in patients with distal radius or ankle fracture: interim analysis","volume":"73","author":"Hjelle","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"key2022103115415165_ref1-bib356","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s12603-013-0017-8","article-title":"Celiac disease is not increased in women with hip fractures and low vitamin D levels","volume":"17","author":"LeBoff","year":"2013","journal-title":"J Nutr Health Aging"},{"key":"key2022103115415165_ref1-bib357","doi-asserted-by":"publisher","first-page":"E849","DOI":"10.3390\/nu10070849","article-title":"A serological diagnosis of coeliac disease is associated with osteoporosis in older Australian adults","volume":"10","author":"Potter","year":"2018","journal-title":"Nutrients"},{"key":"key2022103115415165_ref1-bib358","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1080\/00365520902718929","article-title":"Coeliac disease-specific tissue transglutaminase autoantibodies are associated with osteoporosis and related fractures in middle-aged women","volume":"44","author":"Agardh","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"key2022103115415165_ref1-bib359","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/gut.52.7.960","article-title":"Seroprevalence, correlates, and characteristics of undetected coeliac disease in England","volume":"52","author":"West","year":"2003","journal-title":"Gut"},{"key":"key2022103115415165_ref1-bib360","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1053\/j.gastro.2016.11.043","article-title":"Prevalence and morbidity of undiagnosed celiac disease from a community-based study","volume":"152","author":"Choung","year":"2017","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib361","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1053\/j.gastro.2010.04.007","article-title":"Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study","volume":"139","author":"Walker","year":"2010","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib362","doi-asserted-by":"publisher","first-page":"SP231617","DOI":"10.36295\/ASRO.2020.231617","article-title":"Influence of HLA-DQ on clinical and serological biomarkers in patients with celiac disease","volume":"23","author":"Khudher","year":"2020","journal-title":"Ann Trop Med Public Health"},{"key":"key2022103115415165_ref1-bib363","first-page":"A98","article-title":"Is there a relationship between coeliac disease and inflammatory bowel disease? A bidirectional prevalence study with controls","volume":"55","author":"Horoldt","year":"2006","journal-title":"Gut"},{"key":"key2022103115415165_ref1-bib364","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1080\/00365520701365112","article-title":"Is there an association between coeliac disease and inflammatory bowel diseases? A study of relative prevalence in comparison with population controls","volume":"42","author":"Leeds","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"key2022103115415165_ref1-bib365","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00535-013-0838-6","article-title":"Prevalence of serum celiac antibody in patients with IBD in Japan","volume":"49","author":"Watanabe","year":"2014","journal-title":"J Gastroenterol"},{"key":"key2022103115415165_ref1-bib366","doi-asserted-by":"publisher","first-page":"S370","DOI":"10.1016\/S0016-5085(12)61398-5","article-title":"Celiac disease and inflammatory bowel disease in children: is there a link?","volume":"142","author":"El-Matary","year":"2012","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib367","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s005350050217","article-title":"High frequency of antigliadin antibodies and absence of antireticulin and antiendomysium antibodies in patients with ulcerative colitis","volume":"34","author":"Kull","year":"1999","journal-title":"J Gastroenterol"},{"key":"key2022103115415165_ref1-bib368","first-page":"839","article-title":"Celiac disease: serologic prevalence in patients with irritable bowel syndrome","volume":"17","author":"Mehdi","year":"2012","journal-title":"J Res Med Sci"},{"key":"key2022103115415165_ref1-bib369","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5114\/pg.2013.36333","article-title":"Is it reasonable to perform serological tests for celiac disease in patients with irritable bowel syndrome?","volume":"8","author":"Respondek","year":"2013","journal-title":"Prz Gastroenterol"},{"key":"key2022103115415165_ref1-bib370","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/MEG.0000000000001022","article-title":"Celiac disease is uncommon in irritable bowel syndrome in the USA","volume":"30","author":"Almazar","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key2022103115415165_ref1-bib371","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1053\/j.gastro.2011.06.084","article-title":"The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls","volume":"141","author":"Cash","year":"2011","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib372","doi-asserted-by":"publisher","first-page":"276","DOI":"10.5114\/pg.2016.57941","article-title":"The prevalence of celiac disease in patients with irritable bowel syndrome and its subtypes","volume":"11","author":"Dom\u017ca\u0142-Magrowska","year":"2016","journal-title":"Prz Gastroenterol"},{"key":"key2022103115415165_ref1-bib373","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/1751-2980.12587","article-title":"Prevalence of celiac disease in adult Chinese patients with diarrhea-predominant irritable bowel syndrome: a prospective, controlled, cohort study","volume":"19","author":"Kou","year":"2018","journal-title":"J Dig Dis"},{"key":"key2022103115415165_ref1-bib374","doi-asserted-by":"publisher","first-page":"S472\u2013S","DOI":"10.14309\/00000434-200809001-01208","article-title":"The prevalence of positive serologic tests for celiac sprue does not differ between irritable bowel syndrome (IBS) patients compared with controls","volume":"103","author":"Saito-Loftus","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"key2022103115415165_ref1-bib375","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/nmo.12799","article-title":"Prevalence of celiac disease and related antibodies in patients diagnosed with irritable bowel syndrome according to the Rome III criteria. A case\u2013control study","volume":"28","author":"S\u00e1nchez-Vargas","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"key2022103115415165_ref1-bib376","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/S0140-6736(01)06581-3","article-title":"Association of adult coeliac disease with irritable bowel syndrome: a case\u2013control study in patients fulfilling ROME II criteria referred to secondary care","volume":"358","author":"Sanders","year":"2001","journal-title":"Lancet"},{"key":"key2022103115415165_ref1-bib377","doi-asserted-by":"publisher","first-page":"S252\u2013S","DOI":"10.1016\/S0016-5085(13)60894-X","article-title":"Prevalence of antibodies related to celiac disease (CD) in patients with irritable bowel syndrome (IBS) according to ROME III criteria. A case\u2013control study","volume":"144","author":"Vargas","year":"2013","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib378","doi-asserted-by":"publisher","first-page":"e1779","DOI":"10.1097\/MD.0000000000001779","article-title":"Serological screening for celiac disease in adult Chinese patients with diarrhea predominant irritable bowel syndrome","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine"},{"key":"key2022103115415165_ref1-bib379","first-page":"18","article-title":"Undiagnosed celiac disease in patients presenting with irritable bowel syndrome symptoms","volume":"32","author":"Khayyat","year":"2020","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"key2022103115415165_ref1-bib380","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085(14)60611-9","article-title":"Functional gastrointestinal disorders and the association to celiac disease-a population based screening study in children","volume":"146","author":"Olen","year":"2014","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib381","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-230X-2-5","article-title":"Primary biliary cirrhosis and autoimmune cholangitis are not associated with coeliac disease in Crete","volume":"2","author":"Chatzicostas","year":"2002","journal-title":"BMC Gastroenterology"},{"key":"key2022103115415165_ref1-bib382","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/00004836-200411000-00014","article-title":"Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcome","volume":"38","author":"Durante-Mangoni","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"key2022103115415165_ref1-bib383","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s10620-007-9851-z","article-title":"Chronic hepatitis C virus and celiac disease, is there an association?","volume":"53","author":"Hernandez","year":"2008","journal-title":"Dig Dis Sci"},{"key":"key2022103115415165_ref1-bib384","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3109\/00365529709002997","article-title":"Frequent occurrence of non-specific gliadin antibodies in chronic liver disease. Endomysial but not gliadin antibodies predict coeliac disease in patients with chronic liver disease","volume":"32","author":"Sj\u00f6berg","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"key2022103115415165_ref1-bib385","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3906\/sag-1403-127","article-title":"Serologic testing for celiac disease in young people with elevated transaminases","volume":"45","author":"Yuan","year":"2015","journal-title":"Turk J Med Sci"},{"key":"key2022103115415165_ref1-bib386","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/tropej\/fmq057","article-title":"Celiac disease in children and adolescents with autoimmune hepatitis: a single-centre experience","volume":"57","author":"El-Shabrawi","year":"2011","journal-title":"J Trop Pediatr"},{"key":"key2022103115415165_ref1-bib387","first-page":"79","article-title":"Celiac disease prevalence among children with autoimmune hepatitis and autoimmune thyroid disorders. A 10-years single centre experience","volume":"27","author":"Oana","year":"2018","journal-title":"J Gastrointestin Liver Dis"},{"key":"key2022103115415165_ref1-bib388","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1128\/CDLI.12.8.941-948.2005","article-title":"Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases","volume":"12","author":"Germenis","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"key2022103115415165_ref1-bib389","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/jcla.20047","article-title":"High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue tranglutaminase autoantibodies","volume":"19","author":"Villalta","year":"2005","journal-title":"J Clin Lab Anal"},{"key":"key2022103115415165_ref1-bib390","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1177\/0883073816630088","article-title":"Is celiac disease an etiological factor in children with migraine?","volume":"31","author":"Balci","year":"2016","journal-title":"J Child Neurol"},{"key":"key2022103115415165_ref1-bib391","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1468-2982.2008.01630.x","article-title":"Increased risk for coeliac disease in paediatric patients with migraine","volume":"28","author":"Alehan","year":"2008","journal-title":"Cephalalgia"},{"key":"key2022103115415165_ref1-bib392","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4318\/tjg.2011.0153","article-title":"A comparative study of celiac disease in children with migraine headache and a normal control group","volume":"22","author":"Inaloo","year":"2011","journal-title":"Turk J Gastroenterol"},{"key":"key2022103115415165_ref1-bib393","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1016\/S0022-510X(09)70816-0","article-title":"The association of celiac disease with multiple sclerosis","volume":"285","author":"Abolfazli","year":"2009","journal-title":"J Neurol Sci"},{"key":"key2022103115415165_ref1-bib394","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1177\/1352458507087268","article-title":"Frequency of celiac disease is not increased among multiple sclerosis patients","volume":"14","author":"Nicoletti","year":"2008","journal-title":"Mult Scler"},{"key":"key2022103115415165_ref1-bib395","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2377-11-31","article-title":"Prevalence of celiac disease in multiple sclerosis","volume":"11","author":"Rodrigo","year":"2011","journal-title":"BMC Neurol"},{"key":"key2022103115415165_ref1-bib396","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1365-3083.2008.02115.x","article-title":"Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sj\u00f6gren\u2019s syndrome, multiple sclerosis and Alzheimer\u2019s disease","volume":"67","author":"Roth","year":"2008","journal-title":"Scand J Immunol"},{"key":"key2022103115415165_ref1-bib397","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4149\/bll_2012_109","article-title":"Celiac disease and multiple sclerosis in the northwest of Iran","volume":"113","author":"Khoshbaten","year":"2012","journal-title":"Bratisl Lek Listy"},{"key":"key2022103115415165_ref1-bib398","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1590\/0004-2730000002919","article-title":"Celiac disease screening in Brazilian patients with osteoporosis","volume":"58","author":"Gusso","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"key2022103115415165_ref1-bib399","first-page":"140","article-title":"Is it necessary to screen for celiac disease in adult idiopathic osteoporosis?","volume":"8","author":"Shahbazkhani","year":"2015","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"key2022103115415165_ref1-bib400","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1001\/archinte.165.4.393","article-title":"Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis","volume":"165","author":"Stenson","year":"2005","journal-title":"Arch Intern Med"},{"key":"key2022103115415165_ref1-bib401","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/BF02818684","article-title":"The serologic screening for celiac disease in the general population (blood donors) and in some high-risk groups of adults (patients with autoimmune diseases, osteoporosis and infertility) in the Czech republic","volume":"47","author":"Vancikov\u00e1","year":"2002","journal-title":"Folia Microbiol"},{"key":"key2022103115415165_ref1-bib402","first-page":"578","article-title":"Celiac disease and low femoral bone density in a multiethnic US national survey","volume":"25","author":"Shen","year":"2014","journal-title":"Osteoporos Int"},{"key":"key2022103115415165_ref1-bib403","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000369615","article-title":"Association between coeliac disease and psoriasis: Italian primary care multicentre study","volume":"230","author":"De Bastiani","year":"2015","journal-title":"Dermatology"},{"key":"key2022103115415165_ref1-bib404","doi-asserted-by":"publisher","first-page":"298","DOI":"10.5021\/ad.2013.25.3.298","article-title":"Coeliac disease-associated antibodies in psoriasis","volume":"25","author":"Akbulut","year":"2013","journal-title":"Ann Dermatol"},{"key":"key2022103115415165_ref1-bib405","doi-asserted-by":"publisher","first-page":"e378","DOI":"10.1111\/ajd.13308","article-title":"The association of anti-gliadin and anti-transglutaminase antibodies and chronic plaque psoriasis in Indian patients: preliminary results of a descriptive cross-sectional study","volume":"61","author":"Dhattarwal","year":"2020","journal-title":"Australas J Dermatol"},{"key":"key2022103115415165_ref1-bib406","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2340\/00015555-0960","article-title":"Association between psoriasis and coeliac disease? A case\u2013control study","volume":"91","author":"Montesu","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"key2022103115415165_ref1-bib407","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1365-2230.2010.03980.x","article-title":"Estimation of (IgA) anti-gliadin, anti-endomysium and tissue transglutaminase in the serum of patients with psoriasis","volume":"36","author":"Nagui","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"key2022103115415165_ref1-bib408","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/jcla.20398","article-title":"Celiac disease-associated antibodies in patients with psoriasis and correlation with HLA Cw6","volume":"24","author":"Singh","year":"2010","journal-title":"J Clin Lab Anal"},{"key":"key2022103115415165_ref1-bib409","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1191\/0961203304lu1004oa","article-title":"IgA and IgG tissue transglutaminase antibodies in systemic lupus erythematosus","volume":"13","author":"Marai","year":"2004","journal-title":"Lupus"},{"key":"key2022103115415165_ref1-bib410","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1177\/0961203313503911","article-title":"Spectrum of autoantibodies for gastrointestinal autoimmune diseases in systemic lupus erythematosus patients","volume":"22","author":"Picceli","year":"2013","journal-title":"Lupus"},{"key":"key2022103115415165_ref1-bib411","first-page":"230","article-title":"The frequency of celiac disease in Turkish children with systemic lupus erythematosus","volume":"64","author":"Sahin","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib412","first-page":"247","article-title":"The incidence of latent asymptomatic celiac disease in women with decreased fertility","volume":"78","author":"Ced\u00edkov\u00e1","year":"2013","journal-title":"Ceska Gynekol"},{"key":"key2022103115415165_ref1-bib413","doi-asserted-by":"publisher","first-page":"S468\u2013S","DOI":"10.1016\/S0016-5085(14)61677-2","article-title":"Celiac disease screening in patients previously diagnosed with infertility. A prospective study in Mexican population","volume":"146","author":"Remes-Troche","year":"2014","journal-title":"Gastroenterology"},{"key":"key2022103115415165_ref1-bib414","doi-asserted-by":"publisher","first-page":"i139","DOI":"10.1093\/humrep\/det209","article-title":"Increasing prevalence of undiagnosed celiac disease in Spanish women with recurrent reproductive failure","volume":"28","author":"Herraiz-Nicuesa","year":"2013","journal-title":"Hum Reprod"},{"key":"key2022103115415165_ref1-bib415","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.fertnstert.2010.11.005","article-title":"Latent celiac disease in reproductive performance of women","volume":"95","author":"Kumar","year":"2011","journal-title":"Fertil Steril"},{"key":"key2022103115415165_ref1-bib416","doi-asserted-by":"publisher","first-page":"e13127","DOI":"10.1111\/aji.13127","article-title":"Comparison of celiac disease markers in women with early recurrent pregnancy loss and normal controls","volume":"82","author":"Kutteh","year":"2019","journal-title":"Am J Reprod Immunol"},{"key":"key2022103115415165_ref1-bib417","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/15513815.2017.1346018","article-title":"The association between serological markers of celiac disease and idiopathic recurrent pregnancy loss","volume":"36","author":"Sarikaya","year":"2017","journal-title":"Fetal Pediatr Pathol"},{"key":"key2022103115415165_ref1-bib418","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/j.0001-6349.2004.00592.x","article-title":"Infertility and celiac disease: do we need more than one serological marker?","volume":"83","author":"Shamaly","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key2022103115415165_ref1-bib419","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/j.ajog.2012.10.316","article-title":"Celiac disease serum markers and recurrent pregnancy loss","volume":"208","author":"Sharshiner","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"key2022103115415165_ref1-bib420","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/humrep\/dei314","article-title":"Serological testing for celiac disease in women undergoing assisted reproduction techniques","volume":"21","author":"Tiboni","year":"2006","journal-title":"Hum Reprod"},{"key":"key2022103115415165_ref1-bib421","first-page":"199","article-title":"Prevalence of coeliac disease in infertile women","volume":"68","author":"Zahmatkeshan","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib422","doi-asserted-by":"publisher","first-page":"593","DOI":"10.14309\/ajg.0000000000001148","article-title":"Reproductive characteristics and pregnancy outcomes in hidden celiac disease autoimmunity","volume":"116","author":"Celdir","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"key2022103115415165_ref1-bib423","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/gut.46.3.332","article-title":"Coeliac disease and unfavourable outcome of pregnancy","volume":"46","author":"Martinelli","year":"2000","journal-title":"Gut"},{"key":"key2022103115415165_ref1-bib424","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3923\/tmr.2014.81.97","article-title":"Celiac disease prevalence and its HLA-genotypic profile in Egyptian patients with type 1 diabetes mellitus","volume":"9","author":"Mohammed","year":"2014","journal-title":"Trends Medical Res"},{"key":"key2022103115415165_ref1-bib425","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1365-2249.2005.02866.x","article-title":"Anti-endomysial antibody of IgG1 isotype detection strongly increases the prevalence of coeliac disease in patients affected by type I diabetes mellitus","volume":"142","author":"Picarelli","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"key2022103115415165_ref1-bib426","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1742-1241.2007.01619.x","article-title":"Simultaneous triple organ specific autoantibody profiling in adult patients with type 1 diabetes mellitus and their first-degree relatives","volume":"63","author":"Dagdelen","year":"2009","journal-title":"Int J Clin Pract"},{"key":"key2022103115415165_ref1-bib427","first-page":"103","article-title":"The prevalence of manifest and latent celiac disease in type 1 diabetes mellitus","volume":"13","author":"G\u00fcven\u00e7","year":"2002","journal-title":"Turk J Gastroenterol"},{"key":"key2022103115415165_ref1-bib428","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2337\/diacare.26.4.1235","article-title":"Extrapancreatic autoimmune manifestations in type 1 diabetes patients and their first-degree relatives: a multicenter study","volume":"26","author":"Hanukoglu","year":"2003","journal-title":"Diabetes Care"},{"key":"key2022103115415165_ref1-bib429","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/dme.12163","article-title":"Serological testing for coeliac disease in type 1 diabetes mellitus: is immunoglobulin A level measurement necessary?","volume":"30","author":"Kurien","year":"2013","journal-title":"Diabet Med"},{"key":"key2022103115415165_ref1-bib430","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1515\/jpem-2017-0011","article-title":"High prevalence of organ specific autoantibodies in Indian type 1 diabetic patients","volume":"30","author":"Shivaprasad","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key2022103115415165_ref1-bib431","doi-asserted-by":"publisher","first-page":"e0157510","DOI":"10.1371\/journal.pone.0157510","article-title":"Celiac disease autoimmunity in patients with autoimmune diabetes and thyroid disease among Chinese population","volume":"11","author":"Zhao","year":"2016","journal-title":"PLOS ONE"},{"key":"key2022103115415165_ref1-bib432","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/MPG.0b013e31815ce5d1","article-title":"Prevalence of celiac disease in Egyptian children disputes the east\u2013west agriculture-dependent spread of the disease","volume":"47","author":"Abu-Zekry","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib433","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/pedi.12200","article-title":"Prevalence of celiac disease autoimmunity in children with type 1 diabetes: regional variations across the \u00d8resund strait between Denmark and southernmost Sweden","volume":"16","author":"Adlercreutz","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"key2022103115415165_ref1-bib434","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/00005176-200110000-00008","article-title":"The prevalence and clinical characteristics of celiac disease in juvenile diabetes in Wisconsin","volume":"33","author":"Aktay","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib435","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/01.mpg.0000181400.57884.c3","article-title":"Prevalence of celiac disease in Brazilian children and adolescents with type 1 diabetes mellitus","volume":"41","author":"Baptista","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib436","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1442-200X.2010.03085.x","article-title":"Celiac disease prevalence in children and adolescents with type 1 diabetes from Serbia","volume":"52","author":"Djuri\u0107","year":"2010","journal-title":"Pediatr Int"},{"key":"key2022103115415165_ref1-bib437","first-page":"A72","article-title":"Poor glycemic control and celiac disease autoimmunity are independently associated with reduced bone mineral density in children with type 1 diabetes","volume":"64","author":"Frohnert","year":"2015","journal-title":"Diabetes"},{"key":"key2022103115415165_ref1-bib438","first-page":"39","article-title":"Anti-tissue transglutaminase antibodies in patients with anti-glutamate dehydrogenase positive type 1 diabetes mellitus","volume":"20","author":"Gurau","year":"2012","journal-title":"Rev Romana de Medicina de Lab"},{"key":"key2022103115415165_ref1-bib439","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/apa.12823","article-title":"Silent coeliac disease is over-represented in children with type 1 diabetes and their siblings","volume":"104","author":"Hansson","year":"2015","journal-title":"Acta Paediatr"},{"key":"key2022103115415165_ref1-bib440","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1749-6632.2009.04619.x","article-title":"Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members","volume":"1173","author":"Krause","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"key2022103115415165_ref1-bib441","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4318\/tjg.2010.0093","article-title":"Seroprevalence of autoimmune thyroiditis and celiac disease in children with insulin-dependent diabetes mellitus in the Thrace region of Turkey","volume":"21","author":"Soyucen","year":"2010","journal-title":"Turk J Gastroenterol"},{"key":"key2022103115415165_ref1-bib442","first-page":"S293","article-title":"HLA typing in healthy and diabetic children with celiac disease in Cali, Colombia","volume":"63","author":"Velasco","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key2022103115415165_ref1-bib443","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s001250051593","article-title":"Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with type I diabetes mellitus","volume":"44","author":"Not","year":"2001","journal-title":"Diabetologia"},{"key":"key2022103115415165_ref1-bib444","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1007\/BF03349209","article-title":"Islet cell, thyroid, adrenal and celiac disease related autoantibodies in patients with type 1 diabetes from Sri Lanka","volume":"29","author":"Premawardhana","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"key2022103115415165_ref1-bib445","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2337\/diacare.24.1.27","article-title":"Comparative analysis of organ-specific autoantibodies and celiac disease \u2013 associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects","volume":"24","author":"Jaeger","year":"2001","journal-title":"Diabetes Care"},{"key":"key2022103115415165_ref1-bib446","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1749-6632.2002.tb02976.x","article-title":"Autoantibodies to tissue transglutaminase in patients from eastern India with malnutrition-modulated diabetes mellitus, insulin-dependent diabetes mellitus, and non-insulin-dependent diabetes mellitus","volume":"958","author":"Kanungo","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"key2022103115415165_ref1-bib447","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4318\/tjg.2010.0045","article-title":"Prevalence of celiac disease in Turkish children with type 1 diabetes mellitus and their non-diabetic first-degree relatives","volume":"21","author":"Sari","year":"2010","journal-title":"Turk J Gastroenterol"},{"key":"key2022103115415165_ref1-bib448","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s001250051291","article-title":"Antibodies to tissue transglutaminase C in type I diabetes","volume":"42","author":"Lampasona","year":"1999","journal-title":"Diabetologia"},{"key":"key2022103115415165_ref1-bib449","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/0973-3930.44081","article-title":"Celiac disease in patients with type-1 diabetes mellitus screened by tissue transglutaminase antibodies in northwest of Iran","volume":"28","author":"Sharifi","year":"2008","journal-title":"Int J Diabetes Dev Ctries"},{"key":"key2022103115415165_ref1-bib450","first-page":"49","article-title":"Prevalence of celiac disease in type1 diabetic patients comparing with nondiabetic healthy individuals","volume":"4","author":"Sheikholeslami","year":"2005","journal-title":"J Iran Diabetes Lipid"},{"key":"key2022103115415165_ref1-bib451","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12902-017-0212-4","article-title":"Screening for celiac disease in poorly controlled type 2 diabetes mellitus: worth it or not?","volume":"17","author":"Kizilgul","year":"2017","journal-title":"BMC Endocr Disord"},{"key":"key2022103115415165_ref1-bib452","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5603\/EP.a2016.0017","article-title":"Endocrine autoimmunity in patients with latent autoimmune diabetes in adults (LADA) \u2014 association with HLA genotype","volume":"67","author":"Szepietowska","year":"2016","journal-title":"Endokrynol Pol"},{"key":"key2022103115415165_ref1-bib453","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0531-5565(03)00037-8","article-title":"Increased prevalence of coeliac disease in autoimmune thyroiditis is restricted to aged patients","volume":"38","author":"Ravaglia","year":"2003","journal-title":"Exp Gerontol"},{"key":"key2022103115415165_ref1-bib454","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4183\/aeb.2017.174","article-title":"The relationship between thyroid hormones, antithyroid antibodies, anti-tissue transglutaminase and anti-gliadin antibodies in patients with Hashimoto\u2019s thyroiditis","volume":"13","author":"Riseh","year":"2017","journal-title":"Acta Endocrinol"},{"key":"key2022103115415165_ref1-bib455","doi-asserted-by":"publisher","first-page":"993","DOI":"10.4158\/EP15700.OR","article-title":"HLA DQ2 haplotype, early onset of Graves\u2019 disease, and positive family history of autoimmune disorders are risk factors for developing celiac disease in patients with Graves\u2019 disease","volume":"21","author":"Miskiewicz","year":"2015","journal-title":"Endocr Pract"},{"key":"key2022103115415165_ref1-bib456","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1023\/a:1005441400107","article-title":"Usefulness of screening program for celiac disease in autoimmune thyroiditis","volume":"45","author":"Berti","year":"2000","journal-title":"Dig Dis Sci"},{"key":"key2022103115415165_ref1-bib457","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2265.2005.02214.x","article-title":"Prospective screening for coeliac disease in patients with Graves\u2019 hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies","volume":"62","author":"Ch\u2019ng","year":"2005","journal-title":"Clin Endocrinol"},{"key":"key2022103115415165_ref1-bib458","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3748\/wjg.v13.i10.1599","article-title":"Prevalence of coeliac disease in patients with autoimmune thyroiditis in a Turkish population","volume":"13","author":"Guliter","year":"2007","journal-title":"World J Gastroenterol"},{"key":"key2022103115415165_ref1-bib459","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000048840","article-title":"Coeliac disease in patients with autoimmune thyroiditis","volume":"64","author":"Volta","year":"2001","journal-title":"Digestion"},{"key":"key2022103115415165_ref1-bib460","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10654-006-9002-4","article-title":"Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA\/MONICA Augsburg cohort study 1989\u20131998","volume":"21","author":"Metzger","year":"2006","journal-title":"Eur J Epidemiol"},{"key":"key2022103115415165_ref1-bib461","first-page":"82","article-title":"Glutamic acid decarboxylase (anti-GAD) & tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity","volume":"137","author":"Marwaha","year":"2013","journal-title":"Indian J Med Res"},{"key":"key2022103115415165_ref1-bib462","first-page":"58","article-title":"The frequency of celiac disease in children with autoimmune thyroiditis","volume":"81","author":"Sahin","year":"2018","journal-title":"Acta Gastroenterol Belg"},{"key":"key2022103115415165_ref1-bib463","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s10620-008-0437-1","article-title":"Prevalence of celiac disease in Turkish children with autoimmune thyroiditis","volume":"54","author":"Sari","year":"2009","journal-title":"Dig Dis Sci"},{"key":"key2022103115415165_ref1-bib464","doi-asserted-by":"publisher","first-page":"417356","DOI":"10.1155\/2014\/417356","article-title":"Prevalence of thyroid autoimmunity in children with celiac disease compared to healthy 12-year olds","volume":"2014","author":"van der Pals","year":"2014","journal-title":"Autoimmune Dis"},{"key":"key2022103115415165_ref1-bib465","first-page":"3307","article-title":"Association between autoimmune thyroiditis with gluten sensitive enteropathy patients in Baghdad","volume":"10","author":"Risan","year":"2018","journal-title":"J Pharm Sci Res"},{"key":"key2022103115415165_ref1-bib466","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1590\/S0004-27302005000400012","article-title":"Association between serum markers for celiac and thyroid autoimmune diseases","volume":"49","author":"de Melo","year":"2005","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"key2022103115415165_ref1-bib467","volume-title":"Fertility Problems: Assessment and Treatment","author":"National Institute for Health and Care Excellence"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2040514","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/ZUCE8371\/ZUCE8371.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2040514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T23:13:41Z","timestamp":1701299621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/ZUCE8371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":467,"journal-issue":{"issue":"44","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["10.3310\/ZUCE8371"],"URL":"https:\/\/doi.org\/10.3310\/zuce8371","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"1-2020","name":"contractual_start_date","label":"Contractual start date","group":{"name":"article_history","label":"Article History"}},{"value":"11-2021","name":"editorial_review_begun","label":"Editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"4-2022","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}